Sentence	Label	Term1	Term2
Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to @PROTEIN$1, type IV collagen and @PROTEIN$2, but did inhibit motility of keratinocytes on tissue culture plastic.	0	@PROTEIN$1	@PROTEIN$2
In transfected COS-1 cells, @PROTEIN$1/BMP-7, and less efficiently @PROTEIN$2, bound to BMPR-II.	0	@PROTEIN$1	@PROTEIN$2
Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with @PROTEIN$1, but it interacts more strongly with @PROTEIN$2 and hTAFII30.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 phosphorylates @PROTEIN$2 on serine 41.	1	@PROTEIN$1	@PROTEIN$2
By using the growth factor dependent M-07e cell line, we found that both @PROTEIN$1 and c-Kit ligands, namely: SCF and @PROTEIN$2, induce c-Cbl tyrosine phosphorylation.	0	@PROTEIN$1	@PROTEIN$2
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (@PROTEIN$1) and @PROTEIN$2 (leucine utilization) genes under the control of LexA-dependent operators.	0	@PROTEIN$1	@PROTEIN$2
In the present report, we demonstrated that modulation of @PROTEIN$1 from T cell surface induced by anti@PROTEIN$2 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN$1 (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN$2. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S @PROTEIN$1, which suggests a function for SF3a and SF3b in the incorporation of @PROTEIN$2 into the spliceosome.	0	@PROTEIN$1	@PROTEIN$2
In all cells tested, @PROTEIN$1 activated @PROTEIN$2 and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1; these two complexes may alternatively link FGFG3 to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The catalytic domain of activated @PROTEIN$1 (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Human spleen tyrosine kinase @PROTEIN$1 associates with the Src-family kinase p53/56Lyn and a @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Here we show that beta:beta activin binds to the activin type II receptor kinase (@PROTEIN$1) which induces activin binding to the type I receptor kinase SKR2 to form @PROTEIN$2.beta:beta.	0	@PROTEIN$1	@PROTEIN$2
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN$1) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (@PROTEIN$2), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.	0	@PROTEIN$1	@PROTEIN$2
Involvement of @PROTEIN$1 signal transducer gp130 in @PROTEIN$2-mediated signal transduction.	0	@PROTEIN$1	@PROTEIN$2
IL-2, @PROTEIN$1, IL-7 (whose receptors are known to contain gamma c), and @PROTEIN$2 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN$1 species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$2 respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, @PROTEIN$1, @PROTEIN$2, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and @PROTEIN$1, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN$2 overlap.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 could compete efficiently for @PROTEIN$2 binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.	1	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins @PROTEIN$1, p107 and @PROTEIN$2/p130.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN$1 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$2 respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
RESULTS: TH, AADC and @PROTEIN$1 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-@PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Evidence for a differential interaction of SHC and the @PROTEIN$1 (@PROTEIN$2) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
The encoded product of the @PROTEIN$1 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the @PROTEIN$2(EGF)-like domain gives rise to two isoforms (alpha and beta).	0	@PROTEIN$1	@PROTEIN$2
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (@PROTEIN$1) for @PROTEIN$2 signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.	0	@PROTEIN$1	@PROTEIN$2
IL-7-driven proliferation is mediated via high affinity @PROTEIN$1, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN$2, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.	0	@PROTEIN$1	@PROTEIN$2
We found that ADA was associated with @PROTEIN$1 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between @PROTEIN$2 and ADA did not require enzymatic activity.	0	@PROTEIN$1	@PROTEIN$2
In yeast, @PROTEIN$1 interacts with cyclin-dependent kinases, including human Cdc2, Cdk2, and Cdk3, but not with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN$1 (Immunotech, France), @PROTEIN$2, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Thus, TR6 may play a regulatory role for suppressing in @PROTEIN$1- and @PROTEIN$2-mediated cell death.	0	@PROTEIN$1	@PROTEIN$2
In the case of @PROTEIN$1, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN$2 receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.	0	@PROTEIN$1	@PROTEIN$2
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early @PROTEIN$1 complexes (@PROTEIN$2) or in mature PR complexes (hsp90).	0	@PROTEIN$1	@PROTEIN$2
We found that in addition to @PROTEIN$1, MIP-1alpha, and @PROTEIN$2, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.	0	@PROTEIN$1	@PROTEIN$2
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (@PROTEIN$1) and have identified a novel CC chemokine termed @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
As expected, overexpression of either Id3/@PROTEIN$1 or @PROTEIN$2 effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.	0	@PROTEIN$1	@PROTEIN$2
These cells contain a temperature-sensitive mutation in the @PROT12$ TAFII250, first identified as the cell cycle regulatory protein CCG1.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN$1 gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN$2 with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/@PROTEIN$1) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ @PROTEIN$2, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that @PROTEIN$1 interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of @PROTEIN$2, but not with that of PS-2.	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta (@PROTEIN$2) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of @PROTEIN$1 in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN$2-LPR and Fas-FD8.	0	@PROTEIN$1	@PROTEIN$2
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine @PROT12$ [4].@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
An E2F complex containing mainly E2F4 and @PROTEIN$1/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/@PROTEIN$2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).	0	@PROTEIN$1	@PROTEIN$2
Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of @PROTEIN$1, suggesting that the 66-kDa protein may play an important role in @PROTEIN$2-specific signaling.	0	@PROTEIN$1	@PROTEIN$2
The molar concentration of @PROTEIN$1 required to induce maximum cell migration is 20- to 200-fold greater than that required for RANTES or @PROTEIN$2, respectively.	0	@PROTEIN$1	@PROTEIN$2
Thus, Phe93 and Phe205 are important binding determinants for both EPO and @PROTEIN$1, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the @PROTEIN$2 for productive ligand binding.	1	@PROTEIN$1	@PROTEIN$2
The potency of @PROTEIN$1 as a @PROTEIN$2 ligand seems, however, to be approximately 10-fold less than that of eotaxin.	1	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$1 beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN$2 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Delineation of the binding regions of these three proteins revealed that @PROTEIN$1, @PROTEIN$2, and TFIIB each has two binding regions for the other two proteins.	1	@PROTEIN$1	@PROTEIN$2
Interleukin-13 (@PROTEIN$1) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Among these ligands, @PROTEIN$1 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by @PROTEIN$2 and may therefore be considered as a natural antagonist for CCR5.	0	@PROTEIN$1	@PROTEIN$2
Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the @PROTEIN$1-@PROTEIN$2 complex.	1	@PROTEIN$1	@PROTEIN$2
In yeast, @PROTEIN$1 interacts with cyclin-dependent kinases, including human Cdc2, @PROTEIN$2, and Cdk3, but not with Cdk4.	1	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, @PROTEIN$1/ BR-Ia, @PROTEIN$2/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
Characterization of Fas (@PROTEIN$1, @PROTEIN$2)-Fas ligand interaction.	0	@PROTEIN$1	@PROTEIN$2
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN$1 specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN$2 (upstream binding factor) in vitro.	1	@PROTEIN$1	@PROTEIN$2
CD5 associates with the T-cell receptor zeta chain (@PROTEIN$1)/@PROTEIN$2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.	1	@PROTEIN$1	@PROTEIN$2
The death domain of tumor necrosis factor (TNF) receptor-1 (@PROTEIN$1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the @PROTEIN$1 @PROTEIN$2, and not with expression of the p90 IL-7R.	0	@PROTEIN$1	@PROTEIN$2
RIN1 interacts with the "effector domain" of RAS and employs some @PROTEIN$1 determinants that are common to, and others that are distinct from, those required for the binding of @PROTEIN$2, a known RAS effector.	0	@PROTEIN$1	@PROTEIN$2
The phagocyte NADPH oxidase is a complex of membrane @PROTEIN$1 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
These same @PROTEIN$1 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates @PROTEIN$2 by concealing its transactivation domain.	0	@PROTEIN$1	@PROTEIN$2
The phagocyte @PROTEIN$1 is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Under these conditions, a ternary complex of @PROTEIN$1, @PROTEIN$2, and Raf-1 was observed.	1	@PROTEIN$1	@PROTEIN$2
Two distinct ligand binding domains of @PROTEIN$1 were isolated from proteolytic digests of the receptor by affinity separation on immobilized @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN$1 interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/@PROTEIN$2 related protein, and the Torpedo 87K protein.	0	@PROTEIN$1	@PROTEIN$2
Analysis of the oligomerization of @PROTEIN$1 and @PROTEIN$2 products in vivo using a two-hybrid assay system.	0	@PROTEIN$1	@PROTEIN$2
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by @PROTEIN$1 or @PROTEIN$2 in TF-1 cells.	0	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN$1, YY1, @PROTEIN$2, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin/dystrophin family of @PROTEIN$1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN$2 subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.	0	@PROTEIN$1	@PROTEIN$2
Monomeric (@PROTEIN$1) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the @PROTEIN$2 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.	0	@PROTEIN$1	@PROTEIN$2
We now report the isolation and expression of cDNAs encoding @PROTEIN$1 gamma and @PROTEIN$2 delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.	0	@PROTEIN$1	@PROTEIN$2
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN$1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN$2 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.	0	@PROTEIN$1	@PROTEIN$2
Although the individual amino acids in @PROTEIN$1 involved in binding to @PROTEIN$2 (NGF) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.	1	@PROTEIN$1	@PROTEIN$2
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN$1 (IL-10) receptor, the STAT proteins activated by @PROTEIN$2 in different cell populations were first defined using electrophoretic mobility shift assays.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and @PROTEIN$1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the @PROTEIN$2, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
The formation of native heterotrimeric @PROTEIN$1 complexes, as measured by pertussis toxin ADP-ribosylation of G alpha, could be disrupted by increasing amounts of @PROTEIN$2, with an EC50 of approximately 200 nM, in close agreement with the estimated binding affinity.	0	@PROTEIN$1	@PROTEIN$2
This Syk-@PROTEIN$1 interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and @PROTEIN$2 from an immature B-cell line did not reassociate with Lyn in vitro.	0	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, @PROTEIN$1, fibronectin, @PROTEIN$2, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
Replacement of this loop with the homologous loop from @PROTEIN$1 dramatically reduced both the affinity of FGF-7 for @PROTEIN$2 and its biological potency but did not result in the ability to bind FGFR1.	0	@PROTEIN$1	@PROTEIN$2
Associations of @PROTEIN$1 with @PROTEIN$2, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.	1	@PROTEIN$1	@PROTEIN$2
Comparisons with the hGH-@PROTEIN$1 complex reveal how @PROTEIN$2 can bind to the two distinctly different receptor binding surfaces.	0	@PROTEIN$1	@PROTEIN$2
We found that ADA was associated with CD26 on T cell lines lacking either ADA or @PROTEIN$1 enzymatic activity, indicating that the association between @PROTEIN$2 and ADA did not require enzymatic activity.	0	@PROTEIN$1	@PROTEIN$2
The T-cell antigen @PROTEIN$1 acts as a receptor and substrate for the protein-tyrosine kinase @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
In patients with a complete response to @PROTEIN$1, the levels of @PROTEIN$2 were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.	0	@PROTEIN$1	@PROTEIN$2
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the @PROTEIN$1 (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
We suggest that activation of the cell cycle by the @PROTEIN$1/Raf1 pathways might be mediated in part by @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/@PROTEIN$1 and Grb2/@PROTEIN$2 are present in different complexes.	0	@PROTEIN$1	@PROTEIN$2
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or @PROT12$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
We propose that (i) the @PROTEIN$1 and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) @PROTEIN$2 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.	0	@PROTEIN$1	@PROTEIN$2
The predicted amino acid sequence of @PROTEIN$1 is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an @PROTEIN$2-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.	0	@PROTEIN$1	@PROTEIN$2
Based on the structure of the closely related @PROTEIN$1-tumor necrosis factor receptor I complex, a molecular model of the @PROTEIN$2 homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.	0	@PROTEIN$1	@PROTEIN$2
These results indicate that there is an additional mechanism by which @PROTEIN$1 suppresses cell growth, namely that @PROTEIN$2 directly represses transcription of the rRNA genes.	0	@PROTEIN$1	@PROTEIN$2
Using @PROTEIN$1 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that @PROTEIN$2 interacts with another signaling protein, Grb7.	0	@PROTEIN$1	@PROTEIN$2
Crystal structure of the @PROTEIN$1 cyclin-dependent-kinase inhibitor bound to the @PROTEIN$2-Cdk2 complex.	1	@PROTEIN$1	@PROTEIN$2
The correlation of SRF-@PROTEIN$1 binding with transcriptional activation suggests that @PROTEIN$2 is a critical target for SRF-activated transcription.	0	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / @PROTEIN$1 and LTbetaR , thereby suppressing @PROTEIN$2-mediated HT29 cell death .	0	@PROTEIN$1	@PROTEIN$2
After a brief historical incursion regarding @PROTEIN$1 of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with @PROTEIN$2, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.	0	@PROTEIN$1	@PROTEIN$2
Our data suggest that @PROTEIN$1 inhibits the interactions of @PROTEIN$2 with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.	0	@PROTEIN$1	@PROTEIN$2
This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of @PROTEIN$1 and @PROTEIN$2, does not interact with TIMP-1.	0	@PROTEIN$1	@PROTEIN$2
Thus @PROTEIN$1 is a cellular oncogene that targets PP2A and @PROTEIN$2, both of which are targets for oncogenic viruses and chemical tumour promoters.	1	@PROTEIN$1	@PROTEIN$2
However, @PROTEIN$1 was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN$1 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN$2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.	0	@PROTEIN$1	@PROTEIN$2
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN$1, and cyclin D2-@PROTEIN$2 complexes.	0	@PROTEIN$1	@PROTEIN$2
Association of CDK4 with both CDC37 and HSP90 may also imply a mechanistic link between the functions of @PROTEIN$1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the @PROTEIN$1 (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN$2-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.	0	@PROTEIN$1	@PROTEIN$2
In vitro, purified @PROTEIN$1 subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of @PROTEIN$2 (Raf/330).	1	@PROTEIN$1	@PROTEIN$2
Both GRB2 and @PROTEIN$1 have been implicated in a highly conserved mechanism that regulates @PROTEIN$2 signalling by receptor tyrosine kinases.	0	@PROTEIN$1	@PROTEIN$2
The high affinity interleukin-6 (@PROTEIN$1) signaling complex consists of @PROTEIN$2 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein gp130.	0	@PROTEIN$1	@PROTEIN$2
The IL-1 family currently consists of two agonists, IL-1alpha and @PROTEIN$1, and one antagonist, @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (@PROTEIN$1, collagenase, @PROTEIN$2, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and @PROTEIN$1, induce @PROTEIN$2 tyrosine phosphorylation.	1	@PROTEIN$1	@PROTEIN$2
Functional studies in Jurkat T lymphocytic cells point to the importance of both the @PROTEIN$1 and @PROTEIN$2 binding sites in E2F-1 mediated repression of HIV-1 promoter, in vivo.	0	@PROTEIN$1	@PROTEIN$2
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and @PROTEIN$1, and that @PROTEIN$2 immune complexes exhibit appreciable histone H1 kinase activity.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN$1/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, @PROTEIN$2/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
The interactions between @PROTEIN$1 and these two proteins require ligand activation of the @PROTEIN$2 and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and Shc.	0	@PROTEIN$1	@PROTEIN$2
From Scatchard analyses, the Kd:s for binding of @PROTEIN$1 and bFGF to @PROTEIN$2 were estimated to 25 pM and 41 pM, respectively.	1	@PROTEIN$1	@PROTEIN$2
FGF-7 recognizes one FGFR isoform known as the @PROTEIN$1 isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN$2 but interacts poorly with KGFR.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN$1, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN$2 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN$1 in a semistable TBP-@PROTEIN$2-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.	0	@PROTEIN$1	@PROTEIN$2
Taken together our results demonstrate that @PROTEIN$1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/@PROTEIN$2 complex when non-tyrosine or tyrosine kinase receptors are activated.	0	@PROTEIN$1	@PROTEIN$2
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN$1 and a component (@PROTEIN$2) identical in sequence to the PTF gamma reported here.	0	@PROTEIN$1	@PROTEIN$2
A mutant form of human @PROTEIN$1 (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (@PROTEIN$2 R alpha) has been designed and characterized.	0	@PROTEIN$1	@PROTEIN$2
Here, we demonstrate that TR6 specifically binds two cellular ligands, @PROTEIN$1 (@PROTEIN$2) and Fas ligand (FasL/CD95L).	0	@PROTEIN$1	@PROTEIN$2
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of @PROTEIN$1 and is dependent on tyrosine phosphorylation of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have identified a new TNF-related ligand, designated human @PROT12$ (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Evidence for a differential interaction of @PROTEIN$1 and the insulin receptor substrate-1 (IRS-1) with the @PROTEIN$2 (IGF-I) receptor in the yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or @PROTEIN$1, suggesting that signalling by @PROTEIN$2 is mediated by ErbB3 and/or ErbB4 receptors.	0	@PROTEIN$1	@PROTEIN$2
In this study, we demonstrate that CD5 is coupled to the protein-tyrosine kinase @PROTEIN$1 and can act as a substrate for @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Cotransfection of hGITRL and @PROTEIN$1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and @PROTEIN$2-inducing kinase (NIK) [8].	0	@PROTEIN$1	@PROTEIN$2
In order to characterize the signaling pathway through which @PROTEIN$1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN$2 and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.	0	@PROTEIN$1	@PROTEIN$2
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN$1 gamma and PTF delta with @PROTEIN$2, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.	0	@PROTEIN$1	@PROTEIN$2
Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable @PROTEIN$1 dimer may be an efficient @PROTEIN$2 antagonist.	0	@PROTEIN$1	@PROTEIN$2
Presenilin 1 suppresses the function of @PROTEIN$1 homodimers via interaction with @PROTEIN$2/Jif-1.	0	@PROTEIN$1	@PROTEIN$2
In this recombinant expression system, the dystrophin relatives, human @PROTEIN$1 (@PROTEIN$2 or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN$1 and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase @PROTEIN$1/@PROTEIN$2 (Lyn) contribute to signaling via the B-cell antigen receptor complex.	0	@PROTEIN$1	@PROTEIN$2
Molecular cloning and expression of the 32-kDa subunit of human @PROTEIN$1 reveals interactions with @PROTEIN$2 and TFIIB that mediate transcriptional activation.	0	@PROTEIN$1	@PROTEIN$2
Three naturally occurring ligands for the @PROTEIN$1 receptor (@PROTEIN$2) exist: the agonists IL-1alpha and IL-1beta and the IL-1-receptor antagonist IL1RA (ref. 2).	0	@PROTEIN$1	@PROTEIN$2
When transfected into COS cells the cloned cDNA directed the expression of a GM-CSF-R showing a single class of affinity (KD = 2(-8) nM) and specificity for human @PROTEIN$1 but not @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding @PROTEIN$1/Flk-1, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with @PROTEIN$2 binding.	0	@PROTEIN$1	@PROTEIN$2
The Oct1 POU domain, which is highly homologous to the @PROTEIN$1 POU domain, likewise mediates interaction with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
OBJECTIVE: To assess the usefulness of the molar ratio of serum @PROTEIN$1 (RBP) to transthyretin (@PROTEIN$2) to determine vitamin A (VA) status during infection.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 and RPB5 specifically bound to transcription factor IIB (@PROTEIN$2) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.	0	@PROTEIN$1	@PROTEIN$2
By using several different experimental systems we show that @PROTEIN$1 efficiently associates with @PROTEIN$2 and Oct2.	1	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN$1 (CXCR1) and B (CXCR2) and to the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The binding of IL-1alpha or IL-1beta to @PROTEIN$1 is an early step in @PROTEIN$2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 binds to an alternatively spliced exon of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/@PROTEIN$1 containing @PROTEIN$2 complex of proliferating myoblasts (E2F-G1/S complex).	0	@PROTEIN$1	@PROTEIN$2
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from @PROTEIN$1-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN$2, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.	0	@PROTEIN$1	@PROTEIN$2
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN$1/CCKB G protein-coupled receptor and the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. @PROTEIN$1 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Crystal structure of the hereditary haemochromatosis protein @PROTEIN$1 complexed with @PROTEIN$2 receptor.	0	@PROTEIN$1	@PROTEIN$2
This activation with p85 and @PROTEIN$1 beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN$2 beta (delta C-43).	0	@PROTEIN$1	@PROTEIN$2
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN$1 specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN$2) in vitro.	1	@PROTEIN$1	@PROTEIN$2
A region of the beta subunit of the @PROTEIN$1 different from box 1 interacts with @PROTEIN$2 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state.	1	@PROTEIN$1	@PROTEIN$2
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with @PROTEIN$1, RAD51, @PROTEIN$2, and a ubiquitin-like protein UBL1.	0	@PROTEIN$1	@PROTEIN$2
Here, we demonstrate that TR6 specifically binds two cellular ligands, @PROTEIN$1 (herpes virus entry mediator (HVEM)-L) and Fas ligand (@PROTEIN$2/CD95L).	0	@PROTEIN$1	@PROTEIN$2
CD5 associates with the @PROTEIN$1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN$2/CD3 ligation.	0	@PROTEIN$1	@PROTEIN$2
Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of @PROTEIN$1 proteins which are unable to digest @PROTEIN$2 or beta-casein.	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN$1 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN$2, FGF6, and FGF9.	0	@PROTEIN$1	@PROTEIN$2
HBx and RPB5 specifically bound to @PROTEIN$1 (@PROTEIN$2) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.	0	@PROTEIN$1	@PROTEIN$2
This study demonstrates that @PROTEIN$1 recognizes and activates CXCR1, CXCR2, and the @PROTEIN$2 by distinct mechanisms.	1	@PROTEIN$1	@PROTEIN$2
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, EGFR and @PROTEIN$1, which specifically binds the SH2 domain of @PROTEIN$2 with high affinity.	1	@PROTEIN$1	@PROTEIN$2
The POU domains of the @PROTEIN$1 and @PROTEIN$2 transcription factors mediate specific interaction with TBP.	0	@PROTEIN$1	@PROTEIN$2
One of these proteins, @PROTEIN$1, appears transiently during assembly and is not a component of functionally mature @PROTEIN$2 complexes.	0	@PROTEIN$1	@PROTEIN$2
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to @PROTEIN$1 (@PROTEIN$2) to determine vitamin A (VA) status during infection.	0	@PROTEIN$1	@PROTEIN$2
Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for @PROTEIN$1, @PROTEIN$2 and CCR5, and constitutively expressed by hepatocytes.	0	@PROTEIN$1	@PROTEIN$2
Only weak @PROTEIN$1 binding activity was found in cells transfected with only IL-13Ralpha; however, the combination of both IL-13Ralpha and IL-4Ralpha resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Thus, our data show that both @PROTEIN$1 and @PROTEIN$2 interact with Glut 1 in a glycosylation-dependent manner.	0	@PROTEIN$1	@PROTEIN$2
These findings indicate that the @PROTEIN$1/@PROTEIN$2 and ATF/CREB families of transcription factors are not as distinct as was previously thought.	0	@PROTEIN$1	@PROTEIN$2
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (@PROTEIN$1) with their two known substrates @PROTEIN$2 and the insulin receptor substrate-1 (IRS-1).	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 binding significantly increased hetero- and homo-oligomerization (except for the @PROTEIN$2 homo-oligomer, which binds ligand poorly in the absence of BR-I).	1	@PROTEIN$1	@PROTEIN$2
The Fos/@PROTEIN$1 and @PROTEIN$2/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.	0	@PROTEIN$1	@PROTEIN$2
The crystal structure of the human @PROTEIN$1 inhibitory domain bound to the phosphorylated cyclin A-@PROTEIN$2 (Cdk2) complex has been determined at 2.3 angstrom.	0	@PROTEIN$1	@PROTEIN$2
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin/@PROTEIN$1 family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN$2, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN$1 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN$2 which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the @PROTEIN$1 is essential for the interaction with @PROTEIN$2 and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	1	@PROTEIN$1	@PROTEIN$2
Aggregated @PROTEIN$1 (@PROTEIN$2) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.	0	@PROTEIN$1	@PROTEIN$2
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (@PROTEIN$1), the major cytoplasmic substrate of the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Unlike human @PROTEIN$1 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact @PROTEIN$2, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.	1	@PROTEIN$1	@PROTEIN$2
Thus, @PROTEIN$1 encodes a human FGF receptor with high affinity for both aFGF and @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Peptide growth factors, as well as the immediate early gene products @PROTEIN$1, @PROTEIN$2, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.	0	@PROTEIN$1	@PROTEIN$2
The gamma chain of the @PROTEIN$1 is shared with the functional @PROTEIN$2 and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.	0	@PROTEIN$1	@PROTEIN$2
Monomeric (@PROTEIN$1) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN$2 dimerization on binding to the receptor complex.	0	@PROTEIN$1	@PROTEIN$2
The death domain of @PROTEIN$1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and @PROTEIN$2 activation through its interaction with the death domain protein TRADD.	0	@PROTEIN$1	@PROTEIN$2
We found that ADA was associated with CD26 on T cell lines lacking either @PROTEIN$1 or @PROTEIN$2 enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.	0	@PROTEIN$1	@PROTEIN$2
In this recombinant expression system, the dystrophin relatives, human @PROTEIN$1 related protein (DRP or utrophin) and the @PROTEIN$2 from Torpedo electric organ, also bind to translated beta 1-syntrophin.	0	@PROTEIN$1	@PROTEIN$2
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN$1, p53, @PROTEIN$2 and DPC4/Smad4.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1-TfR complex suggests a binding site for transferrin on @PROTEIN$2 and sheds light upon the function of HFE in regulating iron homeostasis.	0	@PROTEIN$1	@PROTEIN$2
Cotransfection of @PROTEIN$1 and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and @PROTEIN$2-inducing kinase (NIK) [8].	0	@PROTEIN$1	@PROTEIN$2
These analyses showed that the ability of PBMC to proliferate to @PROTEIN$1 correlated with expression of the p76 IL-7R, and not with expression of the @PROTEIN$2 IL-7R.	0	@PROTEIN$1	@PROTEIN$2
We now show that full-length @PROTEIN$1 interacts with activated @PROTEIN$2 in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding.	1	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of LIGHT with @PROTEIN$1 / TR2 and @PROTEIN$2 , thereby suppressing LIGHT-mediated HT29 cell death .	0	@PROTEIN$1	@PROTEIN$2
Taken together, our results suggest that @PROTEIN$1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, @PROTEIN$1 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (@PROTEIN$1) and gp130 have been purified in order to investigate the effect of @PROTEIN$2 dimerization on binding to the receptor complex.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and @PROTEIN$1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Measurement of @PROTEIN$1 I3A,I5A interaction with the human thyroid AKAP, @PROTEIN$2, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.	1	@PROTEIN$1	@PROTEIN$2
Although multimeric complexes of @PROTEIN$1 and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
These data demonstrate that Stat3 but not @PROTEIN$1 or @PROTEIN$2 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	0	@PROTEIN$1	@PROTEIN$2
We have previously reported that tyrosine phosphorylation of Shc and its association with the @PROTEIN$1-Sos complex may contribute to the activation of the @PROTEIN$2 pathway by gastrin.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and @PROTEIN$1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to @PROTEIN$2, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
Here we show that beta:beta activin binds to the activin type II receptor kinase (@PROTEIN$1) which induces activin binding to the type I receptor kinase @PROTEIN$2 to form ActRII.beta:beta.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 complex following @PROTEIN$2 phosphorylation.	0	@PROTEIN$1	@PROTEIN$2
A @PROTEIN$1 fragment retaining the CD4-binding site and overlapping epitopes was able to interact with @PROTEIN$2 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.	1	@PROTEIN$1	@PROTEIN$2
Cotransfection of hGITRL and @PROTEIN$1 in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (@PROTEIN$2) [7] and NF-kappaB-inducing kinase (NIK) [8].	0	@PROTEIN$1	@PROTEIN$2
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, @PROTEIN$1, FLICE/MACH, and TRAFs) associated with both of the p60 and @PROTEIN$2 forms of the TNF receptor and with other members of the TNF receptor superfamily.	0	@PROTEIN$1	@PROTEIN$2
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the calcium effector protein, @PROTEIN$1 (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of @PROTEIN$1 in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN$2, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.	0	@PROTEIN$1	@PROTEIN$2
In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN$1, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (@PROTEIN$2) and ET-3 had a strong positive inotropic effect in all trabeculae.	0	@PROTEIN$1	@PROTEIN$2
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (@PROTEIN$1) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, @PROTEIN$2 and 14-3-3, had no effect.	0	@PROTEIN$1	@PROTEIN$2
Using a soluble CD30L/@PROTEIN$1 chimeric protein, we assessed the ability of anti-@PROTEIN$2 MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.	0	@PROTEIN$1	@PROTEIN$2
A point mutation in FADD, analogous to the lpr mutation of @PROTEIN$1, abolishes its ability to bind @PROTEIN$2, suggesting a death domain to death domain interaction.	0	@PROTEIN$1	@PROTEIN$2
Analysis of p53, p21(CIP1), @PROTEIN$1(INK4b), p16(INK4a), and @PROTEIN$2(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.	0	@PROTEIN$1	@PROTEIN$2
Interactions of the Bcl-2 protein with itself and other members of the @PROTEIN$1 family, including @PROTEIN$2, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
This activation with p85 and @PROTEIN$1 was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN$2 (delta C-43).	0	@PROTEIN$1	@PROTEIN$2
Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and @PROTEIN$1, and that HLA-E expression is @PROTEIN$2-dependent and tapasin-dependent.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN$1, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN$2 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
We observed that the protein HOX11 interacted with protein @PROTEIN$1 catalytic subunit (PP2AC), as well as @PROTEIN$2 (PP1C) in mammalian cells.	0	@PROTEIN$1	@PROTEIN$2
The stimulation of @PROTEIN$1-mediated transcription by RB in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN$1, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN$2-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.	0	@PROTEIN$1	@PROTEIN$2
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (@PROTEIN$1) with their two known substrates p52Shc and the @PROTEIN$2 substrate-1 (IRS-1).	0	@PROTEIN$1	@PROTEIN$2
Gastrin stimulates tyrosine phosphorylation of @PROTEIN$1 substrate 1 and its association with Grb2 and the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Although @PROTEIN$1 associates with @PROTEIN$2 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.	1	@PROTEIN$1	@PROTEIN$2
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of @PROTEIN$1, hsp70, and three additional proteins, p54, p50, and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Association of CDK4 with both @PROTEIN$1 and HSP90 may also imply a mechanistic link between the functions of CDC37 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN$1) protein @PROTEIN$2 and the pocket proteins pRb, p107 and pRb2/p130.	0	@PROTEIN$1	@PROTEIN$2
We have identified a new TNF-related ligand, designated human @PROTEIN$1 (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine @PROTEIN$2 [4].	0	@PROTEIN$1	@PROTEIN$2
In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN$1 does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN$2 overlap.	0	@PROTEIN$1	@PROTEIN$2
Here , we demonstrate that TR6 specifically binds two cellular ligands , @PROTEIN$1 ( @PROTEIN$2 ) and Fas ligand ( FasL / CD95L ) .	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 suppresses the function of @PROTEIN$2 homodimers via interaction with QM/Jif-1.	0	@PROTEIN$1	@PROTEIN$2
Cross-family interaction between the bHLHZip @PROTEIN$1 and bZip Fra1 proteins results in down-regulation of @PROTEIN$2 activity.	0	@PROTEIN$1	@PROTEIN$2
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN$1/MORT, RIP, FLICE/@PROTEIN$2, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.	0	@PROTEIN$1	@PROTEIN$2
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN$1/@PROTEIN$2 ligation.	0	@PROTEIN$1	@PROTEIN$2
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN$1 and @PROTEIN$2, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the @PROTEIN$1 in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the @PROTEIN$2, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
In agreement, mAb to the previously cloned @PROTEIN$1 were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the @PROTEIN$2 IL-7R.	0	@PROTEIN$1	@PROTEIN$2
Both @PROTEIN$1 and hDP-2 bind to all @PROTEIN$2 family members in vivo, and each complex is capable of activating transcription.	0	@PROTEIN$1	@PROTEIN$2
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the @PROTEIN$1-activated @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Liver-expressed chemokine (@PROTEIN$1)/@PROTEIN$2 is a human CC chemokine selectively expressed in the liver.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 was originally identified as a Start gene in budding yeast and has been shown to be required for association of @PROTEIN$2 with cyclins.	0	@PROTEIN$1	@PROTEIN$2
The general transcription factor @PROTEIN$1 nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in @PROTEIN$2-promoter complexes.	0	@PROTEIN$1	@PROTEIN$2
We propose that (i) the IGF-IR and the @PROTEIN$1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and @PROTEIN$2, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.	1	@PROTEIN$1	@PROTEIN$2
Crosslinking of iodinated acidic FGF (@PROTEIN$1) and @PROTEIN$2 (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.	0	@PROTEIN$1	@PROTEIN$2
Surprisingly, the N-terminal third of @PROTEIN$1 alone bound @PROTEIN$2 more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.	1	@PROTEIN$1	@PROTEIN$2
The interactions between GRB2 and these two proteins require ligand activation of the @PROTEIN$1 and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
RIP: a novel protein containing a death domain that interacts with Fas/@PROTEIN$1 (@PROTEIN$2) in yeast and causes cell death.	0	@PROTEIN$1	@PROTEIN$2
The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of @PROTEIN$1 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/@PROTEIN$1 or @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 proteins purified from cells infected with EC12 or 22W viruses activated @PROTEIN$2 kinase from skeletal muscle in vitro.	0	@PROTEIN$1	@PROTEIN$2
Among these ligands, @PROTEIN$1 had the remarkable property of binding @PROTEIN$2 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.	1	@PROTEIN$1	@PROTEIN$2
This region of the betaL chain, required for @PROTEIN$1 binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with @PROTEIN$2 kinases.	0	@PROTEIN$1	@PROTEIN$2
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN$1 by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN$2 complexes.	0	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN$1 and the pocket proteins pRb, p107 and @PROTEIN$2/p130.	0	@PROTEIN$1	@PROTEIN$2
Interaction with @PROTEIN$1 subunit of @PROTEIN$2 is required for transcriptional activation by serum response factor.	0	@PROTEIN$1	@PROTEIN$2
The genes for MPIF-2/eotaxin-2 (@PROTEIN$1) and eotaxin-3 (@PROTEIN$2) are localized within a region of approximately 40 kilobases.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN$1 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN$2. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Here we report that (1) there is an accumulation of @PROTEIN$1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN$2 pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.	0	@PROTEIN$1	@PROTEIN$2
We used alanine substitution of @PROTEIN$1 residues that contact EMP1 in the crystal structure to investigate the function of these residues in both @PROTEIN$2 and EPO binding.	1	@PROTEIN$1	@PROTEIN$2
The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN$1 (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds @PROTEIN$2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.	0	@PROTEIN$1	@PROTEIN$2
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind @PROTEIN$1 (NGF), were substituted with those from human @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, @PROTEIN$1 and @PROTEIN$2 in cell lines expressing all of these ErbB-family receptors.	0	@PROTEIN$1	@PROTEIN$2
The hsp90-@PROTEIN$1-@PROTEIN$2 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.	0	@PROTEIN$1	@PROTEIN$2
However, in cell lines with defined combinations of ErbBs, @PROTEIN$1 only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or @PROTEIN$2 receptors.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of @PROTEIN$2 and to induce a cytotoxic effect against tumor cells.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 (IL-1beta) converting enzyme (ICE) processes the inactive @PROTEIN$2 precursor to the proinflammatory cytokine.	0	@PROTEIN$1	@PROTEIN$2
Crosslinking of iodinated @PROTEIN$1 (aFGF) and @PROTEIN$2 (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN$1)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN$2 and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
TFIID is a multisubunit protein complex comprised of the @PROTEIN$1 (@PROTEIN$2) and multiple TBP-associated factors (TAFs).	0	@PROTEIN$1	@PROTEIN$2
The interaction between @PROTEIN$1 and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN$1)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN$2 alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Interaction of the regulatory subunit (@PROTEIN$1) of @PROTEIN$2 with RII-anchoring proteins occurs through an amphipathic helix binding motif.	0	@PROTEIN$1	@PROTEIN$2
By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of @PROTEIN$1 (CNTF) with CNTFR alpha and not with the beta-components, @PROTEIN$2 and LIFR.	0	@PROTEIN$1	@PROTEIN$2
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed @PROTEIN$1-@PROTEIN$2 interaction was specific.	1	@PROTEIN$1	@PROTEIN$2
Multiple proteins physically interact with @PROTEIN$1. Transcriptional synergy with @PROTEIN$2 (C/EBP delta, CRP3).	0	@PROTEIN$1	@PROTEIN$2
This suggests that one domain of IFN-gamma is sufficient to recruit @PROT12$ and IFN-gamma R beta into a complex competent for eliciting biological activity.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I-@PROTEIN$1 and approximately 5-fold lower affinity for @PROTEIN$2 (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell.	0	@PROTEIN$1	@PROTEIN$2
CONCLUSION: The triple transduction of @PROTEIN$1, @PROTEIN$2 and GCH genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, @PROTEIN$1 is a TFIID beta-specific @PROTEIN$2. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN$1) to be activated by FGF2, FGF6, and @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
A protein ligand for the @PROTEIN$1 receptor protein-tyrosine kinase has been isolated by using the extracellular domain (@PROTEIN$2-X) of the receptor as an affinity reagent.	0	@PROTEIN$1	@PROTEIN$2
Taken together, our results suggest that @PROTEIN$1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the @PROTEIN$2 receptor.	0	@PROTEIN$1	@PROTEIN$2
The beta:@PROTEIN$1 homodimer and alpha:@PROTEIN$2 heterodimer are mutual antagonists which share a common beta subunit.	0	@PROTEIN$1	@PROTEIN$2
This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for @PROTEIN$1 (BMPRIB). collagen types II (@PROTEIN$2) and III (Col III) in a growing "cartilage cap" of osteochondroma.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1-TRAF2 and @PROTEIN$2-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.	0	@PROTEIN$1	@PROTEIN$2
Intriguingly, @PROTEIN$1-@PROTEIN$2 binding is directly antagonized by Ca2+/calmodulin.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 activity and the regulatory @PROTEIN$2 subunit of PI 3-kinase associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.	0	@PROTEIN$1	@PROTEIN$2
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/@PROTEIN$1 heterodimerization may be different from those for Bcl-2/@PROTEIN$2 homodimerization.	0	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of LIGHT with @PROTEIN$1 / @PROTEIN$2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .	0	@PROTEIN$1	@PROTEIN$2
Gastrin stimulates tyrosine phosphorylation of @PROTEIN$1 and its association with @PROTEIN$2 and the phosphatidylinositol 3-kinase.	1	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, IL-1beta, @PROTEIN$1, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN$2 (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of @PROTEIN$1 with HVEM/@PROTEIN$2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.	1	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN$1 and @PROTEIN$2-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 family currently consists of two agonists, IL-1alpha and @PROTEIN$2, and one antagonist, IL-1ra.	0	@PROTEIN$1	@PROTEIN$2
Activation of lacZ upon interaction of p85 with @PROTEIN$1(delta C-43) was 4-fold less as compared to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (@PROTEIN$1) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN$2 proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
p27Kip1 binds the complex as an extended structure interacting with both @PROTEIN$1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN$1. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN$2 species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
The interactions of @PROTEIN$1 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (@PROTEIN$2) or in mature PR complexes (hsp90).	0	@PROTEIN$1	@PROTEIN$2
An E2F complex containing mainly E2F4 and pRb2/p130 (@PROTEIN$1-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing @PROTEIN$2 complex of proliferating myoblasts (E2F-G1/S complex).	0	@PROTEIN$1	@PROTEIN$2
In the present study we evaluated tyrosine phosphorylation of @PROTEIN$1 and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine (@PROTEIN$2) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.	0	@PROTEIN$1	@PROTEIN$2
This information is useful for applying these MAbs in functional studies to further investigate the CD30/@PROTEIN$1 system and for designing assays for soluble @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 @PROTEIN$1 but not T-cell clones that express predominantly the @PROTEIN$2 IL-7R.	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 Cdk-interacting protein @PROTEIN$2 is a potent inhibitor of G1 cyclin-dependent kinases.	0	@PROTEIN$1	@PROTEIN$2
We also show that @PROTEIN$1 is a serine-threonine kinase that is recruited by @PROTEIN$2 to TNFR1 in a TNF-dependent process.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN$2, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	1	@PROTEIN$1	@PROTEIN$2
Associations of UBE2I with @PROTEIN$1, UBL1, @PROTEIN$2, and RAD51 proteins in a yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
The molar ratio of serum retinol-binding protein (@PROTEIN$1) to @PROTEIN$2 (TTR) is not useful to assess vitamin A status during infection in hospitalised children.	0	@PROTEIN$1	@PROTEIN$2
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with @PROTEIN$1 homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and @PROTEIN$2, which interact with guanine nucleotide exchange factors specific for the Ras family.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and @PROTEIN$1/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also @PROTEIN$2/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1, @PROTEIN$2, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.	0	@PROTEIN$1	@PROTEIN$2
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN$1 (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN$2 activity and the inability of cells to re-enter the cell cycle.	0	@PROTEIN$1	@PROTEIN$2
The MDM2 oncoprotein is a cellular inhibitor of the @PROTEIN$1 tumor suppressor in that it can bind the transactivation domain of @PROTEIN$2 and downregulate its ability to activate transcription.	0	@PROTEIN$1	@PROTEIN$2
In differentiating C2C12 cells, @PROTEIN$1 complexes switch and DNA synthesis in response to serum are prevented when @PROTEIN$2 DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.	0	@PROTEIN$1	@PROTEIN$2
The aim of the present study was to elucidate whether intracellular expression of @PROTEIN$1 and @PROTEIN$2 by NK cells might be associated with progression of cancer.	0	@PROTEIN$1	@PROTEIN$2
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and @PROTEIN$1 gene expression elicited by @PROTEIN$2 or IL-6 in TF-1 cells.	0	@PROTEIN$1	@PROTEIN$2
In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or @PROTEIN$1) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
The internal binding site thus revealed was not altered by further mutating Y960/F for @PROTEIN$1 or Y950/F for @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Among these ligands, @PROTEIN$1 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN$2 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN$1 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN$2 which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN$1 (alpha1AT), and complement factors @PROTEIN$2 and C4 can be used in the differential diagnosis of serous effusion.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (neuromodulin, B-50, F1), a @PROTEIN$2 (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.	1	@PROTEIN$1	@PROTEIN$2
An E2F complex containing mainly E2F4 and pRb2/p130 (@PROTEIN$1-G0/G1 complex) appears when DNA synthesis arrests, replacing the @PROTEIN$2/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).	0	@PROTEIN$1	@PROTEIN$2
ICE was also shown to cleave the precursor of @PROTEIN$1 inducing factor (@PROTEIN$2) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN$1. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN$2 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
SF3a interacts with U2 snRNP in the presence of @PROTEIN$1 to generate a structure similar to 17S @PROTEIN$2, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.	0	@PROTEIN$1	@PROTEIN$2
The interaction between @PROTEIN$1 (IL-6) and IL-6 receptor (@PROTEIN$2) is the initial and most specific step in the IL-6 signaling pathway.	1	@PROTEIN$1	@PROTEIN$2
Evidently, large hydrophobic side chains of Leu13 and Phe36 play pivotal roles in stabilizing @PROTEIN$1-@PROTEIN$2 interactions.	1	@PROTEIN$1	@PROTEIN$2
For the calibration, we used two sets of proteins, the @PROTEIN$1-@PROTEIN$2-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.	0	@PROTEIN$1	@PROTEIN$2
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of @PROTEIN$1 amino acids-Phe19, Trp23, and Leu26-which insert deep into the @PROTEIN$2 cleft.	1	@PROTEIN$1	@PROTEIN$2
This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN$1, Bcl-X-L, or Mcl-1 but not those containing @PROTEIN$2 (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) @PROTEIN$1 and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to @PROTEIN$2, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
Three naturally occurring ligands for the IL-1 receptor (IL1R) exist: the agonists @PROTEIN$1 and IL-1beta and the @PROTEIN$2 IL1RA (ref. 2).	0	@PROTEIN$1	@PROTEIN$2
After T cell activation, the phosphorylation of Rb results in the release of @PROTEIN$1, which is correlated temporally with the activation of @PROTEIN$2-mediated transcription.	0	@PROTEIN$1	@PROTEIN$2
We have identified a new TNF-related ligand, designated human GITR ligand (@PROTEIN$1), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (@PROTEIN$2) protein [4].	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/@PROTEIN$2 ligation.	0	@PROTEIN$1	@PROTEIN$2
Measurement of RII alpha I3A,I5A interaction with the human @PROTEIN$1, @PROTEIN$2, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.	0	@PROTEIN$1	@PROTEIN$2
These data imply that @PROTEIN$1-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 @PROTEIN$2 gp130)2 complex.	0	@PROTEIN$1	@PROTEIN$2
Reconstitution of the multiprotein complex of @PROTEIN$1, hsp90, and @PROTEIN$2 in a cell-free system.	0	@PROTEIN$1	@PROTEIN$2
CD9 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of @PROTEIN$1 and @PROTEIN$2, but not of cadherins.	0	@PROTEIN$1	@PROTEIN$2
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, @PROTEIN$1, @PROTEIN$2, and a ubiquitin-like protein UBL1.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN$1, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$2 beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Crystal structure of the hereditary haemochromatosis protein HFE complexed with @PROT12$.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
In this study the origin and function of the @PROTEIN$1 and @PROTEIN$2 molecules have been investigated.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN$2 (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.	0	@PROTEIN$1	@PROTEIN$2
The objective of this study was to measure the concentrations of @PROTEIN$1 (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN$2, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN$2, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	1	@PROTEIN$1	@PROTEIN$2
Deletion analysis indicates that TBP and @PROTEIN$1 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN$2 and hTAFII30.	0	@PROTEIN$1	@PROTEIN$2
These data demonstrate that Stat3 but not Stat1 or @PROTEIN$1 is directly recruited to the ligand-activated @PROTEIN$2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	0	@PROTEIN$1	@PROTEIN$2
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN$1 and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, @PROTEIN$2, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.	0	@PROTEIN$1	@PROTEIN$2
We propose that (i) the IGF-IR and the @PROTEIN$1 share at least in part the same molecular mechanism underlying their interplay with their two substrates, @PROTEIN$2 and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.	1	@PROTEIN$1	@PROTEIN$2
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN$1, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN$2 or a subcomplex lacking TAFII40 and TAFII60 did not.	0	@PROTEIN$1	@PROTEIN$2
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/@PROTEIN$1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/@PROTEIN$2 ligation.	0	@PROTEIN$1	@PROTEIN$2
The same domain of @PROTEIN$1 that binds RAS also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other @PROTEIN$2 effectors.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1, which is known to bind 14-3-3 proteins, has recently been shown to associate with @PROTEIN$2 and to stimulate its phosphatase activity.	1	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (@PROTEIN$1) and B (@PROTEIN$2) and to the Duffy antigen.	0	@PROTEIN$1	@PROTEIN$2
These data demonstrate that @PROTEIN$1 but not Stat1 or @PROTEIN$2 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN$1. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN$2 which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Furthermore, @PROTEIN$1 blocks the ability of PCNA to activate @PROTEIN$2, the principal replicative DNA polymerase.	0	@PROTEIN$1	@PROTEIN$2
HBx and @PROTEIN$1 specifically bound to @PROTEIN$2 (TFIIB) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.	0	@PROTEIN$1	@PROTEIN$2
Thus, @PROTEIN$1 functions as a bridge between @PROTEIN$2 and the enhancer complex to recruit U2AF65 to the adjacent intron.	0	@PROTEIN$1	@PROTEIN$2
Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products @PROTEIN$1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
CIP1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, @PROTEIN$1, and @PROTEIN$2 immunoprecipitates.	0	@PROTEIN$1	@PROTEIN$2
RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the @PROTEIN$1 and @PROTEIN$2 intracellular domains.	0	@PROTEIN$1	@PROTEIN$2
Differential expression of granulysin and @PROTEIN$1 by NK cells in cancer patients and correlation of impaired @PROTEIN$2 expression withprogression of cancer.	0	@PROTEIN$1	@PROTEIN$2
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN$1 interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN$2/dystrophin related protein, and the Torpedo 87K protein.	1	@PROTEIN$1	@PROTEIN$2
PI 3-kinase activity and the regulatory @PROTEIN$1 subunit of @PROTEIN$2 associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, hTAFII18 is a @PROTEIN$1-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN$2 (p32).	0	@PROTEIN$1	@PROTEIN$2
Positive inotropic responses mediated by endothelin @PROTEIN$1 and @PROTEIN$2 receptors in human myocardial trabeculae.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, hTAFII18 is a @PROTEIN$1 beta-specific hTAFII. @PROTEIN$2 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).	0	@PROTEIN$1	@PROTEIN$2
These data demonstrate that the @PROTEIN$1 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the @PROTEIN$2 and p76 IL-7R have different extracellular domains.	0	@PROTEIN$1	@PROTEIN$2
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN$1 and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN$2 beta.	0	@PROTEIN$1	@PROTEIN$2
Thus, @PROTEIN$1 functions as a bridge between U2AF65 and the enhancer complex to recruit @PROTEIN$2 to the adjacent intron.	0	@PROTEIN$1	@PROTEIN$2
The findings suggest a model whereby Bax and @PROTEIN$1 differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for @PROTEIN$2/Bcl-2 homodimerization.	0	@PROTEIN$1	@PROTEIN$2
Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with @PROTEIN$1 and @PROTEIN$2 that mediate transcriptional activation.	0	@PROTEIN$1	@PROTEIN$2
Residues in human leukemia inhibitory factor (@PROTEIN$1) crucial for binding to both the human @PROTEIN$2 (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.	1	@PROTEIN$1	@PROTEIN$2
Only weak IL-13 binding activity was found in cells transfected with only IL-13Ralpha; however, the combination of both @PROTEIN$1 and @PROTEIN$2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the IL-13 receptor.	0	@PROTEIN$1	@PROTEIN$2
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members (ErbB-1, neu/@PROTEIN$1, @PROTEIN$2, and ErbB-4) and tumor recurrence.	0	@PROTEIN$1	@PROTEIN$2
We now report the isolation and expression of cDNAs encoding @PROTEIN$1 gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native @PROTEIN$2 complex in HeLa extracts.	0	@PROTEIN$1	@PROTEIN$2
Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of @PROTEIN$1, @PROTEIN$2 and ErbB4 in cell lines expressing all of these ErbB-family receptors.	0	@PROTEIN$1	@PROTEIN$2
Studies of the @PROTEIN$1 ternary complex formation demonstrated that the reduced biological potency of @PROTEIN$2 resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.	0	@PROTEIN$1	@PROTEIN$2
In contrast, @PROTEIN$1 complexes containing CDK2 are incapable of phosphorylating @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN$1, FADD/MORT, @PROTEIN$2, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.	0	@PROTEIN$1	@PROTEIN$2
RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in @PROTEIN$1:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN$2:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.	0	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (@PROTEIN$1, collagenase, elastin, hyaluronic acid synthase 2, @PROTEIN$2, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
The data thus demonstrate specific binding of platelet FXIII to @PROTEIN$1 and suggest that @PROTEIN$2 may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.	0	@PROTEIN$1	@PROTEIN$2
In the yeast-based cloning system, the only strong interaction that was detected between @PROTEIN$1 and the @PROTEIN$2, calmodulin (CaM).	0	@PROTEIN$1	@PROTEIN$2
We show that the physical interaction between YY1 and @PROTEIN$1, a coactivator for @PROTEIN$2, is not sufficient for repression of CREB-mediated transcription.	1	@PROTEIN$1	@PROTEIN$2
These same p53 residues are also involved in transactivation, supporting the hypothesis that @PROTEIN$1 inactivates @PROTEIN$2 by concealing its transactivation domain.	1	@PROTEIN$1	@PROTEIN$2
Differential expression of @PROTEIN$1 and @PROTEIN$2 by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.	0	@PROTEIN$1	@PROTEIN$2
MATERIALS AND METHODS: We measured levels of IL-8, @PROTEIN$1, @PROTEIN$2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.	0	@PROTEIN$1	@PROTEIN$2
Here we show that QM/@PROTEIN$1, a negative regulator of @PROTEIN$2, is a candidate to mediate the function of PS1 in the cell.	1	@PROTEIN$1	@PROTEIN$2
Biochemical studies established that some coactivators are associated with the @PROTEIN$1 (TBP) to form the @PROTEIN$2 complex.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 complex via the adapter protein @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN$1 receptor (IR) and the @PROTEIN$2 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.	0	@PROTEIN$1	@PROTEIN$2
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the @PROTEIN$1, calmodulin (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Three of these clones encode DNA binding proteins (@PROTEIN$1, HMG I/Y, and @PROTEIN$2), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.	0	@PROTEIN$1	@PROTEIN$2
The interaction between Vav and @PROTEIN$1 is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We found that @PROTEIN$1 was associated with @PROTEIN$2 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.	1	@PROTEIN$1	@PROTEIN$2
The results of this study suggest that @PROTEIN$1 activity may be regulated by its interaction with the cell cycle regulatory protein, @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
The rates of extensive @PROTEIN$1 expression and decreased @PROTEIN$2 expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively).	0	@PROTEIN$1	@PROTEIN$2
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN$1, which leads to the rapid recruitment of @PROTEIN$2, might be one mechanism used by gastrin to activate PI 3-kinase.	0	@PROTEIN$1	@PROTEIN$2
The extracellular domain of the human neurotrophin @PROTEIN$1 receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, @PROTEIN$1, and p21rac) that translocate to membrane and bind to @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROT12$ (delta C-43).@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Molecular studies of the multiprotein @PROTEIN$1 complex have identified a primary @PROTEIN$2 (TBP), TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.	0	@PROTEIN$1	@PROTEIN$2
IL-2, @PROTEIN$1, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases @PROTEIN$2 and Jak3.	0	@PROTEIN$1	@PROTEIN$2
The K-ras, p53, @PROTEIN$1 and @PROTEIN$2 genes are among those most frequently altered in pancreatic ductal carcinoma.	0	@PROTEIN$1	@PROTEIN$2
FGF-7 recognizes one FGFR isoform known as the @PROTEIN$1 isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN$2, and FGFR4 but interacts poorly with KGFR.	0	@PROTEIN$1	@PROTEIN$2
The results of his3 activation indicated that @PROTEIN$1, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN$2, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.	1	@PROTEIN$1	@PROTEIN$2
Molecular studies of the multiprotein @PROTEIN$1 complex have identified a primary TATA binding subunit (@PROTEIN$2), TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.	0	@PROTEIN$1	@PROTEIN$2
Peptide sequencing and Western blot analysis established that the 265-kD protein was @PROTEIN$1 (@PROTEIN$2),a recently identified transcriptional coactivator.	0	@PROTEIN$1	@PROTEIN$2
Measurement of @PROTEIN$1 I3A,I5A interaction with the human @PROTEIN$2, Ht 31, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.	1	@PROTEIN$1	@PROTEIN$2
TRADD-@PROTEIN$1 and @PROTEIN$2-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.	0	@PROTEIN$1	@PROTEIN$2
The interface relies on the steric complementarity between the @PROTEIN$1 cleft and the hydrophobic face of the @PROTEIN$2 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.	0	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN$1 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (@PROTEIN$2) and B (CXCR2) and to the Duffy antigen.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 was first characterized as a receptor for MIP-1alpha, @PROTEIN$2, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).	1	@PROTEIN$1	@PROTEIN$2
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN$1-Cdk2, @PROTEIN$2-Cdk4, and cyclin D2-Cdk4 complexes.	0	@PROTEIN$1	@PROTEIN$2
Tumour-suppressor genes, such as the human @PROTEIN$1 (@PROTEIN$2), are widely recognized as being vital in the control of cell growth and tumour formation.	0	@PROTEIN$1	@PROTEIN$2
It has been shown that @PROTEIN$1 triggers apoptosis of various tumor cells including HT29 cells that express both @PROTEIN$2 ( LTbetaR ) and HVEM / TR2 receptors .	0	@PROTEIN$1	@PROTEIN$2
Secreted LT-alpha is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface @PROTEIN$1-@PROTEIN$2 complex.	1	@PROTEIN$1	@PROTEIN$2
In the present study, we demonstrate that @PROTEIN$1 binds directly to the isolated @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
An E2F complex containing mainly @PROTEIN$1 and @PROTEIN$2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).	1	@PROTEIN$1	@PROTEIN$2
Although IRS-1 is thought to interact with the @PROT12$, the nature of the interaction has not been defined.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
RESULTS: TH, @PROTEIN$1 and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-@PROTEIN$2, AAV-AADC and AAV-GCH.	0	@PROTEIN$1	@PROTEIN$2
The induced expression of @PROTEIN$1, similar to @PROTEIN$2, produces a senescent-like phenotype.	0	@PROTEIN$1	@PROTEIN$2
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of @PROTEIN$1 coimmunoprecipitated with @PROTEIN$2 in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.	1	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, @PROTEIN$1, IL-6, @PROTEIN$2, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Cell surface PS1 formed complexes in vivo with actin-binding protein @PROTEIN$1 (@PROTEIN$2), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.	0	@PROTEIN$1	@PROTEIN$2
It was observed that anti-@PROTEIN$1 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by @PROTEIN$2 or IL-6 in TF-1 cells.	0	@PROTEIN$1	@PROTEIN$2
Here, a direct interaction between the activation domain of p53 and two subunits of the @PROTEIN$1 complex, @PROTEIN$2 and TAFII60, is reported.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is shown to interact with the largest subunit (@PROTEIN$2) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	1	@PROTEIN$1	@PROTEIN$2
Analysis of p53, p21(@PROTEIN$1), p15(INK4b), p16(@PROTEIN$2), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.	0	@PROTEIN$1	@PROTEIN$2
In competition experiments, the carboxyl terminus of @PROTEIN$1 (beta ARK) blocked the binding of G beta gamma to @PROTEIN$2; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) @PROTEIN$1 and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, @PROTEIN$2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by @PROTEIN$1(-) @PROTEIN$2(+) cells in healthy controls.	0	@PROTEIN$1	@PROTEIN$2
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN$1 and beta, transforming growth factors (TGF) beta1 and 2, @PROTEIN$2 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.	0	@PROTEIN$1	@PROTEIN$2
Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN$1 (PKC), binds @PROTEIN$2 at a site distinct from those bound by PKA or CaN.	0	@PROTEIN$1	@PROTEIN$2
The molar ratio of serum retinol-binding protein (@PROTEIN$1) to transthyretin (@PROTEIN$2) is not useful to assess vitamin A status during infection in hospitalised children.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (@PROTEIN$2)/CCL16 is a human CC chemokine selectively expressed in the liver.	0	@PROTEIN$1	@PROTEIN$2
We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and @PROTEIN$1, and (ii) @PROTEIN$2 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN$1 (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN$2 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of @PROTEIN$1 from the cytoplasm to the nucleus and to thereby suppress the binding of @PROTEIN$2 homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).	0	@PROTEIN$1	@PROTEIN$2
Two lines of evidence support the notion that @PROTEIN$1 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with @PROTEIN$2 for binding to Rb.	0	@PROTEIN$1	@PROTEIN$2
Eotaxin-3 induced transient calcium mobilization specifically in @PROTEIN$1 (@PROTEIN$2)-expressing L1.2 cells with an EC(50) of 3 nM.	0	@PROTEIN$1	@PROTEIN$2
The IL-1 family currently consists of two agonists, @PROTEIN$1 and IL-1beta, and one antagonist, @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN$1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN$2 from rat brain.	0	@PROTEIN$1	@PROTEIN$2
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either @PROTEIN$1 or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both @PROTEIN$2 and TFIIB.	0	@PROTEIN$1	@PROTEIN$2
Finally, activated FGFR3 was also found to result in phosphorylation of @PROTEIN$1 but reduced phosphorylation of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$1 respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN$2 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
It was observed that anti-@PROTEIN$1 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or @PROTEIN$2 in TF-1 cells.	0	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN$1 receptor subtypes A (@PROTEIN$2) and B (CXCR2) and to the Duffy antigen.	1	@PROTEIN$1	@PROTEIN$2
The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and @PROTEIN$1 and @PROTEIN$2 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN$1 present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN$2 and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Microinjection of anti-@PROTEIN$1 antibodies into HeLa cells causes their arrest in mitosis. cdc25A and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either @PROTEIN$2 or B2 but not A or D1.	0	@PROTEIN$1	@PROTEIN$2
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained @PROTEIN$1 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (@PROTEIN$1, p67-phox, and @PROTEIN$2) that translocate to membrane and bind to cytochrome b558.	0	@PROTEIN$1	@PROTEIN$2
Both the GT155-@PROTEIN$1 and the @PROTEIN$2-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 showed genetic interactions with the CDC28 gene, suggesting that it functioned at START by interacting with the @PROTEIN$2 protein.	1	@PROTEIN$1	@PROTEIN$2
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex @PROTEIN$1, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (@PROTEIN$2) protein.	0	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins @PROTEIN$1, @PROTEIN$2 and pRb2/p130.	0	@PROTEIN$1	@PROTEIN$2
LexA protein fused to the Drosophila protein bicoid (LexA-@PROTEIN$1) failed to interact with the B42 fragment fused to Abeta, indicating that the observed @PROTEIN$2-Abeta interaction was specific.	0	@PROTEIN$1	@PROTEIN$2
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and @PROTEIN$1-inducing kinase (@PROTEIN$2) [8].	0	@PROTEIN$1	@PROTEIN$2
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the @PROTEIN$1 SH2 domain, with the SCF-activated @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 also interacts weakly with the p55 tumor necrosis factor receptor (@PROTEIN$2) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.	1	@PROTEIN$1	@PROTEIN$2
LexA protein fused to the Drosophila protein @PROTEIN$1 (LexA-bicoid) failed to interact with the @PROTEIN$2 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.	0	@PROTEIN$1	@PROTEIN$2
Nuclear extracts deficient in @PROTEIN$1 were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, @PROTEIN$1/@PROTEIN$2, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.	0	@PROTEIN$1	@PROTEIN$2
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the @PROT12$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Mutational analysis of p60 indicates that the N terminus is required for @PROTEIN$1 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Associations of @PROTEIN$1 with RAD52, UBL1, @PROTEIN$2, and RAD51 proteins in a yeast two-hybrid system.	1	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN$1, CTF, adenoviral @PROTEIN$2, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
Interferon-gamma, @PROTEIN$1 and @PROTEIN$2 levels were statistically greater in patients.	0	@PROTEIN$1	@PROTEIN$2
DCs express more @PROTEIN$1 and @PROTEIN$2 mRNA than T cells.	0	@PROTEIN$1	@PROTEIN$2
Here we show that Vav and @PROTEIN$1 form inducible molecular complexes in @PROTEIN$2-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.	0	@PROTEIN$1	@PROTEIN$2
To determine the role of each of these receptors in @PROTEIN$1 driven proliferation, @PROTEIN$2 expression and proliferative capacity were monitored during mitogenic stimulation.	0	@PROTEIN$1	@PROTEIN$2
SF3a interacts with @PROTEIN$1 in the presence of @PROTEIN$2 to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.	0	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN$1 (bHLH) protein MyoD and the pocket proteins pRb, p107 and @PROTEIN$2/p130.	0	@PROTEIN$1	@PROTEIN$2
This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (@PROTEIN$1). collagen types II (@PROTEIN$2) and III (Col III) in a growing "cartilage cap" of osteochondroma.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN$1 present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN$2 beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
These results suggest that @PROTEIN$1 and @PROTEIN$2 partly differ in function.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN$1 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN$2 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
The products of the RBP1 and @PROTEIN$1 genes are ubiquitously expressed, large (200 kDa for @PROTEIN$2 and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.	0	@PROTEIN$1	@PROTEIN$2
Cytokines @PROTEIN$1, IL-1beta, @PROTEIN$2, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
We screened for proteins that bind to PS1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the @PROTEIN$1/@PROTEIN$2 gene.	0	@PROTEIN$1	@PROTEIN$2
Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two @PROTEIN$1 and two @PROTEIN$2 molecules.	1	@PROTEIN$1	@PROTEIN$2
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that @PROTEIN$1 uses components of the @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, @PROTEIN$1, and a ubiquitin-like protein @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Substitution of Ala for Leu13 or Phe36 generates monomeric @PROTEIN$1 subunits that cannot bind @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN$1 (CXCR1) and B (@PROTEIN$2) and to the Duffy antigen.	0	@PROTEIN$1	@PROTEIN$2
In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN$1, @PROTEIN$2 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor TFIIB.	0	@PROTEIN$1	@PROTEIN$2
Furthermore, a partial TFIID complex containing Drosophila @PROTEIN$1 (@PROTEIN$2), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.	0	@PROTEIN$1	@PROTEIN$2
A double point mutation in the activation domain of p53 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both @PROTEIN$1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Interaction of p85 subunit of PI 3-kinase with @PROTEIN$1 and @PROTEIN$2 receptors analysed by using the two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
Both the @PROTEIN$1-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN$2, a characteristic of many calnexin interactions.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, hTAFII18 is a @PROTEIN$1-specific hTAFII. hTAFII20 is the homologue of @PROTEIN$2, an alternatively spliced form of dTAFII30 alpha (p32).	0	@PROTEIN$1	@PROTEIN$2
The products of the @PROTEIN$1 and @PROTEIN$2 genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.	0	@PROTEIN$1	@PROTEIN$2
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN$1 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN$2) in vitro.	0	@PROTEIN$1	@PROTEIN$2
Analysis of p53, @PROTEIN$1(CIP1), p15(INK4b), p16(INK4a), and @PROTEIN$2(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.	0	@PROTEIN$1	@PROTEIN$2
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the @PROTEIN$1 IL-7R is a previously undescribed splice variant of the cloned @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Three naturally occurring ligands for the IL-1 receptor (IL1R) exist: the agonists @PROTEIN$1 and IL-1beta and the IL-1-receptor antagonist @PROTEIN$2 (ref. 2).	0	@PROTEIN$1	@PROTEIN$2
pRB, @PROTEIN$1, p19(INK4d) and @PROTEIN$2(KIP1) decrease in both cell types.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 interacts with protein phosphatases PP2A and @PROTEIN$2 and disrupts a G2/M cell-cycle checkpoint.	1	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of @PROTEIN$1 with HVEM/TR2 and @PROTEIN$2, thereby suppressing LIGHT- mediated HT29 cell death.	1	@PROTEIN$1	@PROTEIN$2
CD5 associates with the @PROTEIN$1 (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/@PROTEIN$2 ligation.	0	@PROTEIN$1	@PROTEIN$2
The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). @PROTEIN$1 expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 interacts with CCR5 and SDF-1 with @PROTEIN$2 receptors.	0	@PROTEIN$1	@PROTEIN$2
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN$1 interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN$2 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 binds independently to two transmembrane receptors, the @PROTEIN$2 and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.	1	@PROTEIN$1	@PROTEIN$2
This activation with @PROTEIN$1 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN$2 (delta C-43).	1	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, @PROTEIN$1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the @PROTEIN$2 and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
Additionally, in the absence of @PROTEIN$1, an interaction between a two-domain @PROTEIN$2 fragment and CCR-5 was observed.	0	@PROTEIN$1	@PROTEIN$2
Two lines of evidence support the notion that RbAP46 and @PROTEIN$1 have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with @PROTEIN$2 for binding to Rb.	0	@PROTEIN$1	@PROTEIN$2
Two human genes were identified that could interact with @PROTEIN$1 to perform START in yeast containing a @PROTEIN$2 mutation.	0	@PROTEIN$1	@PROTEIN$2
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase @PROTEIN$1 to form @PROTEIN$2.beta:beta.	0	@PROTEIN$1	@PROTEIN$2
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (@PROTEIN$1)2 complex to couple with the soluble portion of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
This activation with @PROTEIN$1 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN$2 beta (delta C-43).	0	@PROTEIN$1	@PROTEIN$2
For the calibration, we used two sets of proteins, the Myc-@PROTEIN$1-@PROTEIN$2 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.	0	@PROTEIN$1	@PROTEIN$2
Two lines of evidence support the notion that RbAP46 and @PROTEIN$1 have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with @PROTEIN$2; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.	0	@PROTEIN$1	@PROTEIN$2
pRB, cyclin D, p19(INK4d) and @PROTEIN$1(@PROTEIN$2) decrease in both cell types.	0	@PROTEIN$1	@PROTEIN$2
Gastrin stimulates tyrosine phosphorylation of @PROTEIN$1 receptor substrate 1 and its association with @PROTEIN$2 and the phosphatidylinositol 3-kinase.	0	@PROTEIN$1	@PROTEIN$2
Additionally we have examined interactions between TFIIH components, the human NER protein @PROTEIN$1, and the @PROTEIN$2 protein which is implicated in Cockayne syndrome (CS).	0	@PROTEIN$1	@PROTEIN$2
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and @PROTEIN$1 (@PROTEIN$2) [8].	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN$1-@PROTEIN$2 and Fas-FD8.	0	@PROTEIN$1	@PROTEIN$2
We show that hTAFII28 interacts with @PROTEIN$1 both in vitro and intracellularly; in contrast to its Drosophila homologue, @PROTEIN$2 also interacts directly with TBP.	0	@PROTEIN$1	@PROTEIN$2
The analysis of complexes of @PROTEIN$1 with CSF proteins in a KBr gradient revealed an association of @PROTEIN$2 only with free proteins and not with lipoprotein particles.	0	@PROTEIN$1	@PROTEIN$2
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the @PROTEIN$1/@PROTEIN$2 signal transduction pathway.	0	@PROTEIN$1	@PROTEIN$2
CD5 associates with the @PROTEIN$1 (@PROTEIN$2)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.	0	@PROTEIN$1	@PROTEIN$2
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN$1 and the pocket proteins pRb, p107 and pRb2/@PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits @PROTEIN$1 and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and @PROTEIN$2) that translocate to membrane and bind to cytochrome b558.	0	@PROTEIN$1	@PROTEIN$2
When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to IL-1, @PROTEIN$1 rapidly associated with the @PROTEIN$2 complex and was phosphorylated.	1	@PROTEIN$1	@PROTEIN$2
The results showed that IL-11 and @PROTEIN$1 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (@PROTEIN$2) expression in TF-1 cells.	1	@PROTEIN$1	@PROTEIN$2
This suggests that one domain of @PROTEIN$1 is sufficient to recruit @PROTEIN$2 R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.	0	@PROTEIN$1	@PROTEIN$2
14-3-3 zeta negatively regulates @PROTEIN$1 activity by interactions with the @PROTEIN$2 cysteine-rich domain.	0	@PROTEIN$1	@PROTEIN$2
Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated @PROTEIN$1 (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
The extracellular domain of the human @PROT12$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Thus , @PROTEIN$1 may play a regulatory role for suppressing in @PROTEIN$2- and LIGHT-mediated cell death .	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 encodes a novel 21 kd protein that is found in cyclin A, @PROTEIN$2, cyclin E, and Cdk2 immunoprecipitates.	0	@PROTEIN$1	@PROTEIN$2
Shared and unique determinants of the @PROTEIN$1 are important for binding EPO and @PROTEIN$2 mimetic peptide.	0	@PROTEIN$1	@PROTEIN$2
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either @PROTEIN$1 or RPB5 in a mutually exclusive manner, suggesting that @PROTEIN$2 transactivation requires the interactions of both RPB5 and TFIIB.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 inhibited @PROTEIN$2-induced cytotoxicity in HT29 cells .	0	@PROTEIN$1	@PROTEIN$2
We have exploited the availability of the cloned @PROTEIN$1, XPD, @PROTEIN$2, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.	0	@PROTEIN$1	@PROTEIN$2
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN$1 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
These findings strongly suggest that @PROTEIN$1 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of @PROTEIN$2 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN$1 (@PROTEIN$2-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ @PROTEIN$1, BR-Ib/ @PROTEIN$2, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
However, MIP-1 beta was also an agonist for @PROTEIN$1 but not CC CKR1; MCP-3 was an agonist for @PROTEIN$2 but not CC CKR3.	0	@PROTEIN$1	@PROTEIN$2
TNF-dependent recruitment of the protein kinase @PROTEIN$1 to the @PROTEIN$2 signaling complex.	0	@PROTEIN$1	@PROTEIN$2
Expressions of @PROTEIN$1, @PROTEIN$2 and GCH were detected by Western blot analysis.	0	@PROTEIN$1	@PROTEIN$2
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN$1-@PROTEIN$2 complexes.	1	@PROTEIN$1	@PROTEIN$2
Two lines of evidence support the notion that @PROTEIN$1 and simian virus 40 T antigen have homologous @PROTEIN$2-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.	1	@PROTEIN$1	@PROTEIN$2
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal @PROTEIN$1 binding inhibition was 80% for @PROTEIN$2, but only 30% for MIP-1beta.	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is a @PROTEIN$2 that controls progression through G1 of the mammalian cell cycle.	0	@PROTEIN$1	@PROTEIN$2
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or @PROTEIN$1 but not those containing @PROTEIN$2 (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).	0	@PROTEIN$1	@PROTEIN$2
The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-@PROTEIN$1 (@PROTEIN$2) complex has been determined at 2.3 angstrom.	0	@PROTEIN$1	@PROTEIN$2
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (@PROTEIN$1) and HVEM/@PROTEIN$2 receptors.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the @PROTEIN$2 gene products E12 and E47.	0	@PROTEIN$1	@PROTEIN$2
The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [@PROTEIN$1 (@PROTEIN$2)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN$1) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN$2 binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.	0	@PROTEIN$1	@PROTEIN$2
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated @PROTEIN$1, that interacts with RAD52, @PROTEIN$2, p53, and a ubiquitin-like protein UBL1.	1	@PROTEIN$1	@PROTEIN$2
Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds @PROTEIN$1 at a site distinct from those bound by @PROTEIN$2 or CaN.	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN$1, which binds Fas and Fas-FD5, a mutant of @PROTEIN$2 possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.	0	@PROTEIN$1	@PROTEIN$2
In the case of @PROTEIN$1, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN$2 does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.	0	@PROTEIN$1	@PROTEIN$2
In a number of human T cell clones, expression of @PROTEIN$1 mRNA is down-regulated after activation of the cells with anti-@PROTEIN$2 Ab and phorbol ester.	0	@PROTEIN$1	@PROTEIN$2
In addition, activation of PI 3-kinase was detected in anti-@PROTEIN$1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN$2 to activate PI 3-kinase.	0	@PROTEIN$1	@PROTEIN$2
Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. @PROTEIN$1 also interacts with TBP, but it interacts more strongly with @PROTEIN$2 and hTAFII30.	1	@PROTEIN$1	@PROTEIN$2
We have identified a new TNF-related ligand, designated human GITR ligand (@PROTEIN$1), and its human receptor (@PROTEIN$2), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN$2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN$1/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ @PROTEIN$2) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN$2 activity toward MEK-1 in mammalian cells.	0	@PROTEIN$1	@PROTEIN$2
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN$1 ligands, @PROTEIN$2 and MIP-1beta (refs 7, 8).	0	@PROTEIN$1	@PROTEIN$2
The retinoblastoma-susceptibility gene product binds directly to the human @PROT12$ TAFII250.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-@PROTEIN$1 proteins are able to form complexes with @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
The amount of CDK4 and @PROTEIN$1 associated with @PROTEIN$2 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.	1	@PROTEIN$1	@PROTEIN$2
Although @PROTEIN$1 is a critical effector of @PROTEIN$2 signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN$1 species which either lack or contain hTAFII30 (@PROTEIN$2 alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Cloning and characterization of @PROTEIN$1, hTAFII20 and @PROTEIN$2: three subunits of the human transcription factor TFIID.	1	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN$1. @PROTEIN$2 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
We propose that @PROTEIN$1 and c-Jun proteins function as transcriptional activators, in part by recruiting @PROTEIN$2 to form complexes to initiate RNA synthesis.	1	@PROTEIN$1	@PROTEIN$2
In this study, we demonstrate that @PROTEIN$1 is coupled to the protein-tyrosine kinase p56lck and can act as a substrate for @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and @PROTEIN$1) and the BMP type II receptor (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of @PROTEIN$1 and @PROTEIN$2 bound to DNA.	1	@PROTEIN$1	@PROTEIN$2
An arginine side chain (arginine-789) of @PROTEIN$1 is supplied into the active site of @PROTEIN$2 to neutralize developing charges in the transition state.	0	@PROTEIN$1	@PROTEIN$2
In this report, it is demonstrated that @PROTEIN$1 contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of @PROTEIN$2 both in vitro and in vivo.	1	@PROTEIN$1	@PROTEIN$2
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN$1), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The interaction between interleukin-6 (IL-6) and @PROT12$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
GAP-43 (@PROTEIN$1, B-50, F1), a protein kinase C (@PROTEIN$2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.	1	@PROTEIN$1	@PROTEIN$2
The death domain of @PROTEIN$1 (@PROTEIN$2) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.	0	@PROTEIN$1	@PROTEIN$2
The Fos/@PROTEIN$1 and ATF/@PROTEIN$2 families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN$1.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN$2-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.	0	@PROTEIN$1	@PROTEIN$2
SREBP transcriptional activity is mediated through an interaction with the @PROT12$.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Thus , TR6 may play a regulatory role for suppressing in @PROTEIN$1- and @PROTEIN$2-mediated cell death .	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (@PROTEIN$1/BR-II, @PROTEIN$2/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN$1 or FGF10 and the epithelial splice form of @PROTEIN$2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN$1/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ @PROTEIN$2, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned @PROTEIN$1, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN$1-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN$2 activity and the inability of cells to re-enter the cell cycle.	0	@PROTEIN$1	@PROTEIN$2
The self-association site appears to be formed by interactions between helices 1 and 2 of @PROTEIN$1 repeat 17 of one dimer with helix 3 of @PROTEIN$2 repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.	1	@PROTEIN$1	@PROTEIN$2
Identification of an 11-kDa @PROTEIN$1-rapamycin-binding domain within the 289-kDa @PROTEIN$2 and characterization of a critical serine residue.	0	@PROTEIN$1	@PROTEIN$2
Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and @PROTEIN$1 [calcineurin (@PROTEIN$2)] are complexed by an A kinase anchoring protein, AKAP79.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 (Flk-1) and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Lipopolysaccharide-activated @PROTEIN$1-deficient (ICE-/-) Kupffer cells synthesized the @PROTEIN$2 precursor but failed to process it into the active form.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROT12$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
At relatively high concentrations, LEC induced calcium mobilization and chemotaxis via @PROTEIN$1 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Association between cdc25A and @PROTEIN$1/@PROTEIN$2 was detected in the HeLa cells.	0	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN$1, YY1, USF, CTF, adenoviral @PROTEIN$2, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN$1 beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and @PROTEIN$1/@PROTEIN$2) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	1	@PROTEIN$1	@PROTEIN$2
In addition, activation of @PROTEIN$1 was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN$2, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN$1) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN$2) to be activated by FGF2, FGF6, and FGF9.	0	@PROTEIN$1	@PROTEIN$2
Their order of selection was alpha1AT effusion, @PROTEIN$1 serum, @PROTEIN$2-effusion, and C3 effusion.	0	@PROTEIN$1	@PROTEIN$2
In the present study, we demonstrate that @PROTEIN$1 stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN$2 receptor.	0	@PROTEIN$1	@PROTEIN$2
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, @PROTEIN$1 and CXCR-4, respectively, as well as the primary receptor @PROTEIN$2 (refs 1-6).	0	@PROTEIN$1	@PROTEIN$2
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (@PROTEIN$1) and @PROTEIN$2 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/@PROTEIN$1 and BR-II/BR-Ib) and homomeric (@PROTEIN$2/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN$1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN$1, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN$2-FD8.	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN$1 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN$2) to be activated by FGF2, FGF6, and FGF9.	0	@PROTEIN$1	@PROTEIN$2
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN$1 receptor, but neither of these proteins binds @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
In vitro experiments showed that the stable @PROTEIN$1/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
These data demonstrate that Stat3 but not @PROTEIN$1 or Stat5 is directly recruited to the ligand-activated @PROTEIN$2 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	0	@PROTEIN$1	@PROTEIN$2
Sos; these two complexes may alternatively link @PROTEIN$1 to @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
In contrast to hTAFII28, hTAFII18 is a @PROT12$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of @PROTEIN$1 and a protein of approximately 60 kDa designated @PROTEIN$2 (calnexin-associated protein of 60 kDa).	1	@PROTEIN$1	@PROTEIN$2
The SH2/SH3-containing protein @PROTEIN$1 also contains a guanine nucleotide exchange factor domain, and Vav has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, @PROTEIN$1, IL-6, IL-8, @PROTEIN$2 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
A point mutation in @PROTEIN$1, analogous to the lpr mutation of Fas, abolishes its ability to bind @PROTEIN$2, suggesting a death domain to death domain interaction.	1	@PROTEIN$1	@PROTEIN$2
Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human @PROTEIN$1 are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human mdm-2-@PROTEIN$2 protein in vitro.	0	@PROTEIN$1	@PROTEIN$2
Analysis of p53, @PROTEIN$1(CIP1), p15(INK4b), p16(INK4a), and p57(@PROTEIN$2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.	0	@PROTEIN$1	@PROTEIN$2
LexA protein fused to the Drosophila protein bicoid (LexA-@PROTEIN$1) failed to interact with the @PROTEIN$2 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.	0	@PROTEIN$1	@PROTEIN$2
By using the growth factor dependent M-07e cell line, we found that both @PROTEIN$1 and c-Kit ligands, namely: @PROTEIN$2 and TPO, induce c-Cbl tyrosine phosphorylation.	0	@PROTEIN$1	@PROTEIN$2
Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa @PROTEIN$1-rapamycin-binding domain within @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Here we show that TRADD directly interacts with @PROTEIN$1 and FADD, signal transducers that activate @PROTEIN$2 and induce apoptosis, respectively.	1	@PROTEIN$1	@PROTEIN$2
The findings suggest a model whereby Bax and @PROTEIN$1 differentially regulate Bcl-2 function, and indicate that requirements for @PROTEIN$2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.	0	@PROTEIN$1	@PROTEIN$2
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to @PROTEIN$1, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have exploited the availability of the cloned XPB, XPD, p62, @PROTEIN$1, and @PROTEIN$2 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.	0	@PROTEIN$1	@PROTEIN$2
We suggest that activation of the cell cycle by the @PROTEIN$1/@PROTEIN$2 pathways might be mediated in part by Cdc25.	0	@PROTEIN$1	@PROTEIN$2
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing @PROTEIN$1-MyoD (@PROTEIN$2-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.	0	@PROTEIN$1	@PROTEIN$2
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and @PROTEIN$1 through communication with @PROTEIN$2 and TFIIB.	0	@PROTEIN$1	@PROTEIN$2
Transient expression in COS-1 cells and immunoprecipitation using an antiserum raised against a C-terminal peptide, gave rise to two components, representing mature (130 kDa) and precursor (115 kDa) forms of the @PROTEIN$1 encoded polypeptide, which was denoted @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Evidence for a differential interaction of SHC and the @PROTEIN$1 (IRS-1) with the insulin-like growth factor-I (@PROTEIN$2) receptor in the yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN$1 complexes containing @PROTEIN$2 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).	0	@PROTEIN$1	@PROTEIN$2
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN$1, dTAFII60, and @PROTEIN$2 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.	0	@PROTEIN$1	@PROTEIN$2
Expression of @PROTEIN$1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN$2-expressing cells responded only to FGF-1.	0	@PROTEIN$1	@PROTEIN$2
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN$1 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the @PROTEIN$2 gene encoding the ligand binding domain.	0	@PROTEIN$1	@PROTEIN$2
The cloned @PROTEIN$1 gene encodes a member of a protein family that includes the yeast @PROTEIN$2 protein, a component of the transcriptional regulator Swi/Snf.	0	@PROTEIN$1	@PROTEIN$2
The physical interaction between @PROTEIN$1 and @PROTEIN$2 may thus form the basis for the functional interplay observed previously.	1	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 enzymes @PROTEIN$2 and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.	0	@PROTEIN$1	@PROTEIN$2
Shared and unique determinants of the @PROT12$ are important for binding EPO and EPO mimetic peptide.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of @PROTEIN$1 to Raf/330; however, the @PROTEIN$2-binding proteins, Ras and 14-3-3, had no effect.	0	@PROTEIN$1	@PROTEIN$2
The SH2/SH3 domain-containing protein @PROTEIN$1 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of @PROTEIN$2 signalling.	0	@PROTEIN$1	@PROTEIN$2
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with @PROTEIN$1, RAD51, p53, and a ubiquitin-like protein @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Our finding that HBx directly interacts with RNA polymerase II subunit 5 (@PROTEIN$1), a common subunit of RNA polymerases, implies that @PROTEIN$2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).	0	@PROTEIN$1	@PROTEIN$2
Moreover, using immunoelectron microscopy, we demonstrated that @PROTEIN$1 and @PROTEIN$2 co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.	0	@PROTEIN$1	@PROTEIN$2
The similarities in biofunctions and differences in ligand binding proteins between IL-11 and @PROTEIN$1 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with @PROTEIN$1 and/or @PROTEIN$2, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.	0	@PROTEIN$1	@PROTEIN$2
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (@PROTEIN$1) to @PROTEIN$2 homodimers and PDGF receptor-alpha/beta heterodimers.	1	@PROTEIN$1	@PROTEIN$2
This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROT12$ (CXCR1) and B (CXCR2) and to the Duffy antigen.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
We studied the human IL-6 (@PROTEIN$1)/@PROTEIN$2 binding interface by a combination of molecular modelling and site-directed mutagenesis.	1	@PROTEIN$1	@PROTEIN$2
This activation with p85 and IGF-1R beta was 4-fold less as compared to @PROTEIN$1 and was somewhat increased (2-fold) for @PROTEIN$2 beta (delta C-43).	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 and @PROTEIN$2 are two proteins that have critical roles in the regulation of apoptosis and the cell cycle.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN$1)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN$2, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN$1 through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN$2 proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
Computer-aided analysis of secondary structure, performed on four @PROTEIN$1-anchoring protein sequences (the microtubule-associated protein 2, @PROTEIN$2, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.	0	@PROTEIN$1	@PROTEIN$2
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN$1) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN$2 or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.	0	@PROTEIN$1	@PROTEIN$2
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the @PROTEIN$1 (IR) with their two known substrates @PROTEIN$2 and the insulin receptor substrate-1 (IRS-1).	1	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1 oncoprotein is a cellular inhibitor of the @PROTEIN$2 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.	1	@PROTEIN$1	@PROTEIN$2
Type I interferons bind to two cell surface receptors, @PROTEIN$1 and @PROTEIN$2, as the first step in the activation of several signal transduction pathways that elicit an anti-viral state and an anti-proliferative response.	0	@PROTEIN$1	@PROTEIN$2
Our results indicate that the @PROTEIN$1 and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity @PROTEIN$2 binding sites.	0	@PROTEIN$1	@PROTEIN$2
Interactions of @PROTEIN$1, a mediator of progesterone receptor assembly, with heat shock proteins @PROTEIN$2 and hsp70.	1	@PROTEIN$1	@PROTEIN$2
The phagocyte NADPH oxidase is a complex of membrane @PROTEIN$1 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, @PROTEIN$2, and p21rac) that translocate to membrane and bind to cytochrome b558.	0	@PROTEIN$1	@PROTEIN$2
Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of @PROTEIN$1 and @PROTEIN$2 receptors in embryonic spinal cord and brain tissues enriched in the two receptors.	0	@PROTEIN$1	@PROTEIN$2
This largest TAF may therefore play a central role in @PROTEIN$1 assembly by interacting with both @PROTEIN$2 and other TAFs, as well as serving to link the control of transcription to the cell cycle.	0	@PROTEIN$1	@PROTEIN$2
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN$1, @PROTEIN$2, p16 and DPC4/Smad4.	0	@PROTEIN$1	@PROTEIN$2
Cloning of the complete coding region for human @PROTEIN$1 using the two hybrid system and expression of @PROTEIN$2 in E. coli.	0	@PROTEIN$1	@PROTEIN$2
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one @PROTEIN$1 receptor alpha chain (@PROTEIN$2) has been designed and characterized.	0	@PROTEIN$1	@PROTEIN$2
When the ligand binds, @PROTEIN$1 initiates a signaling cascade that results in the activation of the transcription regulator @PROTEIN$2 (NF-kappa B).	0	@PROTEIN$1	@PROTEIN$2
The same domain of RIN1 that binds @PROTEIN$1 also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other @PROTEIN$2 effectors.	0	@PROTEIN$1	@PROTEIN$2
Characterization of @PROTEIN$1 (Apo-1, @PROTEIN$2)-Fas ligand interaction.	0	@PROTEIN$1	@PROTEIN$2
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN$1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin/dystrophin family of @PROTEIN$2-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.	0	@PROTEIN$1	@PROTEIN$2
In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the @PROTEIN$1 and @PROTEIN$2, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.	0	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, @PROTEIN$1, @PROTEIN$2, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (@PROTEIN$1), which is distantly related to @PROTEIN$2, a BMP type II receptor from Caenorhabditis elegans.	0	@PROTEIN$1	@PROTEIN$2
The predicted amino acid sequence of @PROTEIN$1 is 60% identical and 73% similar to mouse IL-10R (@PROTEIN$2). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1, a member of the @PROTEIN$2 superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.	0	@PROTEIN$1	@PROTEIN$2
Taken together, these data suggest that JAK2 and @PROTEIN$1 cooperate to activate @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
However, @PROTEIN$1 was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for @PROTEIN$2 but not CC CKR3.	0	@PROTEIN$1	@PROTEIN$2
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN$1) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN$2) identical in sequence to the PTF gamma reported here.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, @PROTEIN$2, and CCL16.	0	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, IL-1beta, @PROTEIN$1, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN$2) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of @PROTEIN$1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The findings suggest a model whereby Bax and @PROTEIN$1 differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/@PROTEIN$2 homodimerization.	0	@PROTEIN$1	@PROTEIN$2
The binding epitopes of @PROTEIN$1 for @PROTEIN$2 (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.	1	@PROTEIN$1	@PROTEIN$2
Deletion analysis indicates that @PROTEIN$1 and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN$2 and hTAFII30.	0	@PROTEIN$1	@PROTEIN$2
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN$1, which binds Fas and Fas-@PROTEIN$2, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.	1	@PROTEIN$1	@PROTEIN$2
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN$1, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and @PROTEIN$2 forms of the TNF receptor and with other members of the TNF receptor superfamily.	1	@PROTEIN$1	@PROTEIN$2
The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of @PROTEIN$1 to phosphotyrosines on both IRS-1 and @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Their order of selection was @PROTEIN$1 effusion, C4 serum, TNFalpha-effusion, and @PROTEIN$2 effusion.	0	@PROTEIN$1	@PROTEIN$2
We find that p53, @PROTEIN$1(@PROTEIN$2) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.	0	@PROTEIN$1	@PROTEIN$2
The tyrosine kinases Flt4, @PROTEIN$1, and Flk1 (or @PROTEIN$2) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.	0	@PROTEIN$1	@PROTEIN$2
CSA protein interacts with @PROTEIN$1 protein and with @PROTEIN$2 protein, a subunit of the human RNA polymerase II transcription factor IIH.	0	@PROTEIN$1	@PROTEIN$2
We found that in addition to MIP-1beta, @PROTEIN$1, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and @PROTEIN$2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.	0	@PROTEIN$1	@PROTEIN$2
Our analyses demonstrate that the XPB, @PROTEIN$1, @PROTEIN$2, and p62 proteins interact with each other.	0	@PROTEIN$1	@PROTEIN$2
Here , we demonstrate that @PROTEIN$1 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / @PROTEIN$2 ) .	1	@PROTEIN$1	@PROTEIN$2
By using the growth factor dependent M-07e cell line, we found that both @PROTEIN$1 and @PROTEIN$2 ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.	0	@PROTEIN$1	@PROTEIN$2
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing @PROTEIN$1-Abeta bait when the B42 transactivation domain was fused to an @PROTEIN$2 fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and @PROTEIN$1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to @PROTEIN$2, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN$1 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Here, a direct interaction between the activation domain of @PROTEIN$1 and two subunits of the TFIID complex, @PROTEIN$2 and TAFII60, is reported.	1	@PROTEIN$1	@PROTEIN$2
Finally, anti-@PROTEIN$1 antibody inhibited the ability of @PROTEIN$2, but not IL-11, to transduce early signals in TF-1 cells.	0	@PROTEIN$1	@PROTEIN$2
The reciprocal loop replacement mutant (@PROTEIN$1-L4/7) retained FGF-2 like affinity for FGFR1 and for @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
A few general transcription factors, in particular @PROTEIN$1 and @PROTEIN$2, have been found to bind transcriptional activators.	0	@PROTEIN$1	@PROTEIN$2
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, @PROTEIN$1, and @PROTEIN$2, which interact with guanine nucleotide exchange factors specific for the Ras family.	0	@PROTEIN$1	@PROTEIN$2
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN$1 IIIc, that result from alternative splicing of exon III of the @PROTEIN$2 gene encoding the ligand binding domain.	0	@PROTEIN$1	@PROTEIN$2
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/@PROTEIN$1) and homomeric (BR-II/@PROTEIN$2, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.	0	@PROTEIN$1	@PROTEIN$2
Competition binding and immunoprecipitation studies on cells bearing both @PROTEIN$1 and beta receptors reveal a high affinity binding of recombinant GFD (@PROTEIN$2) to PDGF receptor-alpha homodimers and PDGF receptor-alpha/beta heterodimers.	0	@PROTEIN$1	@PROTEIN$2
The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of @PROTEIN$1 to phosphotyrosines on both @PROTEIN$2 and Shc.	1	@PROTEIN$1	@PROTEIN$2
In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN$1 receptor, but hGH binds to both the hGHR and @PROTEIN$2, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROT12$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
The @PROTEIN$1/@PROTEIN$2 and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN$2, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.	1	@PROTEIN$1	@PROTEIN$2
Analysis of @PROTEIN$1, p21(CIP1), p15(INK4b), p16(INK4a), and p57(@PROTEIN$2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.	0	@PROTEIN$1	@PROTEIN$2
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN$1), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN$2 (p48).	0	@PROTEIN$1	@PROTEIN$2
Deletion of the complete active-site [des-(161-228)-@PROTEIN$1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
COS-7 cells transfected with the @PROTEIN$1 cDNA bind @PROTEIN$2 with high affinity but do not bind IL-4.	1	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN$1, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN$2, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Here, we demonstrate that TR6 specifically binds two cellular ligands, @PROTEIN$1 (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/@PROTEIN$2).	0	@PROTEIN$1	@PROTEIN$2
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/@PROTEIN$1 heterodimers, consistent with the reported function of QM/@PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The molecular adapter @PROTEIN$1 is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, @PROTEIN$2, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.	1	@PROTEIN$1	@PROTEIN$2
Secreted @PROTEIN$1 is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface LT-alpha-@PROTEIN$2 complex.	0	@PROTEIN$1	@PROTEIN$2
Cleavage of @PROTEIN$1 by @PROTEIN$2 and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.	1	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 and Jak3 associated with @PROTEIN$2 and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.	1	@PROTEIN$1	@PROTEIN$2
We observed that the protein HOX11 interacted with protein @PROTEIN$1 (PP2AC), as well as protein phosphatase 1 (@PROTEIN$2) in mammalian cells.	0	@PROTEIN$1	@PROTEIN$2
This activation with p85 and @PROTEIN$1 beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (@PROTEIN$23).	0	@PROTEIN$1	@PROTEIN$2
Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of @PROTEIN$1. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN$2 and hTAFII30.	0	@PROTEIN$1	@PROTEIN$2
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one @PROTEIN$1 receptor alpha chain (@PROTEIN$2 R alpha) has been designed and characterized.	0	@PROTEIN$1	@PROTEIN$2
The reciprocal loop replacement mutant (FGF2-L4/7) retained FGF-2 like affinity for @PROTEIN$1 and for @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The binding epitopes of BMP-2 for @PROTEIN$1 (type I) and @PROTEIN$2 or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.	0	@PROTEIN$1	@PROTEIN$2
MAIN OUTCOME MEASURES: Measurement of soluble @PROTEIN$1 (@PROTEIN$2) and IL-1alpha in serum samples and fluid of recent blisters.	0	@PROTEIN$1	@PROTEIN$2
OBJECTIVE: To assess the usefulness of the molar ratio of serum @PROTEIN$1 (RBP) to @PROTEIN$2 (TTR) to determine vitamin A (VA) status during infection.	0	@PROTEIN$1	@PROTEIN$2
We observed that the protein @PROTEIN$1 interacted with protein @PROTEIN$2 (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.	1	@PROTEIN$1	@PROTEIN$2
We found that deletion of the carboxyl-terminal 28 amino acids of PU.1 disrupted @PROTEIN$1-@PROTEIN$2 physical interaction.	1	@PROTEIN$1	@PROTEIN$2
A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the @PROTEIN$1 tyrosine kinase and @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Further investigation indicated that the @PROTEIN$1/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/@PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The screen identified interactions involving c-Cbl and two 14-3-3 isoforms, @PROTEIN$1, human unconventional myosin IC, and a recently identified SH3 domain containing protein, @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN$1 by @PROTEIN$2-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.	0	@PROTEIN$1	@PROTEIN$2
The interaction between interleukin-6 (@PROTEIN$1) and IL-6 receptor (@PROTEIN$2) is the initial and most specific step in the IL-6 signaling pathway.	0	@PROTEIN$1	@PROTEIN$2
Of these 400, interferon regulatory factor 4 (@PROTEIN$1), @PROTEIN$2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.	0	@PROTEIN$1	@PROTEIN$2
We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN$1 (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
CD5 interaction w@PROTEIN$1 p56lck represents a novel variant of a receptor-kinas@PROTEIN$2ex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )	0	@PROTEIN$1	@PROTEIN$2
Concentrations of glial fibrillary acidic protein (GFAp) and @PROTEIN$1 (@PROTEIN$2) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.	0	@PROTEIN$1	@PROTEIN$2
Cytokines IL-1alpha, @PROTEIN$1, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN$2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).	0	@PROTEIN$1	@PROTEIN$2
Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN$1 (@PROTEIN$2), binds AKAP79 at a site distinct from those bound by PKA or CaN.	0	@PROTEIN$1	@PROTEIN$2
A physical interaction between @PROTEIN$1 and @PROTEIN$2 suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on CDK4.	1	@PROTEIN$1	@PROTEIN$2
Using immunoprecipitation techniques, we have determined the rates at which @PROTEIN$1 and glutamine synthetase (GS) are released from @PROTEIN$2 in a form committed to refold to active enzyme.	1	@PROTEIN$1	@PROTEIN$2
This regulation results from a direct interaction between @PROTEIN$1 and @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein @PROTEIN$1, regulated on activation, normal T expressed and secreted (RANTES), and monocyte chemoattractant protein-3 (@PROTEIN$2), but the receptors involved have not been defined.	0	@PROTEIN$1	@PROTEIN$2
Regulation of the @PROTEIN$1-related transcription factor @PROTEIN$2 by binding to the retinoblastoma protein.	0	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, @PROTEIN$1, elastin, @PROTEIN$2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
This @PROTEIN$1-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-@PROTEIN$2 associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.	0	@PROTEIN$1	@PROTEIN$2
CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor @PROTEIN$1 (also known as the MIP-1 alpha/@PROTEIN$2 receptor).	0	@PROTEIN$1	@PROTEIN$2
Since @PROTEIN$1 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-@PROTEIN$2-hsp70 complex.	0	@PROTEIN$1	@PROTEIN$2
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN$1 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN$2 amino acids 83-218.	0	@PROTEIN$1	@PROTEIN$2
Interaction of @PROTEIN$1 subunit of PI 3-kinase with @PROTEIN$2 and IGF-1 receptors analysed by using the two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
RESULTS: TH, @PROTEIN$1 and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-@PROTEIN$2 and AAV-GCH.	0	@PROTEIN$1	@PROTEIN$2
Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN$1 kinase activity toward @PROTEIN$2 in mammalian cells.	0	@PROTEIN$1	@PROTEIN$2
Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to @PROTEIN$1, @PROTEIN$2 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.	0	@PROTEIN$1	@PROTEIN$2
The cloned @PROTEIN$1 gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator @PROTEIN$2/Snf.	0	@PROTEIN$1	@PROTEIN$2
One was @PROTEIN$1, and the second was the human homolog of Xenopus @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, @PROTEIN$1 and @PROTEIN$2, and is thought to regulate signalling by many cell surface receptors.	0	@PROTEIN$1	@PROTEIN$2
Competitive binding of @PROTEIN$1 and calmodulin to the @PROTEIN$2.	1	@PROTEIN$1	@PROTEIN$2
We have exploited the availability of the cloned XPB, XPD, @PROTEIN$1, p44, and p34 genes (all of which encode polypeptide subunits of @PROTEIN$2) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.	0	@PROTEIN$1	@PROTEIN$2
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN$1, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN$2 proteins--through a distinct amino-terminal domain.	0	@PROTEIN$1	@PROTEIN$2
Using a protein interaction cloning technique, we identified cDNAs that encode a novel @PROTEIN$1, termed @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
We have used site-specific mutagenesis within the extracellular domain of the EPOR to search for amino acid residues involved in @PROTEIN$1 (@PROTEIN$2) binding.	0	@PROTEIN$1	@PROTEIN$2
Interferon-gamma and several other cytokines that are known to activate @PROT12$ were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN$1 (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN$2 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.	0	@PROTEIN$1	@PROTEIN$2
Identification of a critical ligand binding determinant of the human @PROT12$. Evidence for common ligand binding motifs in the cytokine receptor family.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Levels of p16(INK4a) and @PROTEIN$1(KIP2) rise in HUCs during progressive passages, whereas only @PROTEIN$2 increases in HPEC cultures.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (TTR), a second major CSF protein, formed SDS-stable complexes with @PROTEIN$2 and significantly decreased the rate of A beta fibril formation.	1	@PROTEIN$1	@PROTEIN$2
Interestingly, both @PROTEIN$1 and @PROTEIN$2 can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.	0	@PROTEIN$1	@PROTEIN$2
Native @PROTEIN$1 and @PROTEIN$2 formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.	1	@PROTEIN$1	@PROTEIN$2
Association of @PROTEIN$1 with both @PROTEIN$2 and HSP90 may also imply a mechanistic link between the functions of CDC37 and HSP90.	1	@PROTEIN$1	@PROTEIN$2
Interactions of the Bcl-2 protein with itself and other members of the @PROTEIN$1 family, including Bcl-X-L, Bcl-X-S, @PROTEIN$2, and Bax, were explored with a yeast two-hybrid system.	0	@PROTEIN$1	@PROTEIN$2
Here we show that beta:@PROTEIN$1 binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase @PROTEIN$2 to form ActRII.beta:beta.	0	@PROTEIN$1	@PROTEIN$2
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN$1 and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), @PROTEIN$2 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 (@PROTEIN$2) is a major substrate of the insulin receptor and has been implicated in insulin signaling.	0	@PROTEIN$1	@PROTEIN$2
The correlation of @PROTEIN$1-@PROTEIN$2 binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.	1	@PROTEIN$1	@PROTEIN$2
The interleukin-1beta (@PROTEIN$1) converting enzyme (ICE) processes the inactive @PROTEIN$2 precursor to the proinflammatory cytokine.	0	@PROTEIN$1	@PROTEIN$2
Together, these results suggest that TAFII40 and @PROTEIN$1 are important targets for transmitting activation signals between @PROTEIN$2 and the initiation complex.	1	@PROTEIN$1	@PROTEIN$2
The genes for @PROTEIN$1/@PROTEIN$2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.	0	@PROTEIN$1	@PROTEIN$2
A @PROTEIN$1 mutant that was not glycosylated (AGGT155) did not associate with @PROTEIN$2 or CAP-60.	0	@PROTEIN$1	@PROTEIN$2
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of @PROTEIN$1 by @PROTEIN$2 and may therefore be considered as a natural antagonist for CCR5.	1	@PROTEIN$1	@PROTEIN$2
Our data suggest that TR6 inhibits the interactions of @PROTEIN$1 with @PROTEIN$2/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.	1	@PROTEIN$1	@PROTEIN$2
The amount of CDK4 and @PROTEIN$1 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with @PROTEIN$2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.	0	@PROTEIN$1	@PROTEIN$2
Our data suggest that @PROTEIN$1 inhibits the interactions of LIGHT with HVEM / @PROTEIN$2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .	0	@PROTEIN$1	@PROTEIN$2
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; @PROTEIN$1 induced Jak3-IL-2R beta and increased @PROTEIN$2-gamma c associations.	0	@PROTEIN$1	@PROTEIN$2
This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN$1, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of @PROTEIN$2 that lacks a well-conserved 63-amino acid region).	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and @PROTEIN$2 immunoprecipitates.	0	@PROTEIN$1	@PROTEIN$2
Recombinant @PROTEIN$1 induces the tyrosine-phosphorylation of @PROTEIN$2, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.	1	@PROTEIN$1	@PROTEIN$2
As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted @PROTEIN$1 multiprotein complex contains hsp70, which is a major candidate for providing the protein unfoldase activity required for @PROTEIN$2 association.	0	@PROTEIN$1	@PROTEIN$2
Deletion of this domain impairs @PROTEIN$1's ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support @PROTEIN$2-activated transcription.	0	@PROTEIN$1	@PROTEIN$2
@PROTEIN$1 protein fused to the Drosophila protein @PROTEIN$2 (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.	0	@PROTEIN$1	@PROTEIN$2
CCR5 was first characterized as a receptor for MIP-1alpha, @PROTEIN$1, and @PROTEIN$2, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).	0	@PROTEIN$1	@PROTEIN$2
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, CCR-5 and @PROTEIN$1, respectively, as well as the primary receptor @PROTEIN$2 (refs 1-6).	0	@PROTEIN$1	@PROTEIN$2
Both the GT155-calnexin and the @PROTEIN$1-@PROTEIN$2 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.	1	@PROTEIN$1	@PROTEIN$2
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, @PROTEIN$1, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and @PROTEIN$2) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.	0	@PROTEIN$1	@PROTEIN$2
We demonstrate here that both the site 2 and site 3 @PROTEIN$1 variants complexed with IL-6R alpha bind a single @PROTEIN$2 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130.	1	@PROTEIN$1	@PROTEIN$2
Although many different types of proliferating cells contain @PROTEIN$1 protein, neither the interactions of @PROTEIN$2 with cyclin/CDK complexes nor the consequences of this interaction during the mitotic cycle have been fully explored.	0	@PROTEIN$1	@PROTEIN$2
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN$1 gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN$2 in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.	0	@PROTEIN$1	@PROTEIN$2
Specifically, substitution of proline for Ala-498 significantly diminished @PROT12$ binding, and similar mutation of Ile-502 or Ile-507 abolished interaction.@PROTEIN$1NA@PROTEIN$2	0	@PROTEIN$1	@PROTEIN$2
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits @PROTEIN$1, hTAF31 and @PROTEIN$2.	0	@PROTEIN$1	@PROTEIN$2
Flow cytometric analysis demonstrated high levels of perforin and @PROTEIN$1 expression by CD3(-) @PROTEIN$2(+) cells in healthy controls.	0	@PROTEIN$1	@PROTEIN$2
